WO2024042613A1 - Terminal, method for controlling terminal, and storage medium - Google Patents

Terminal, method for controlling terminal, and storage medium Download PDF

Info

Publication number
WO2024042613A1
WO2024042613A1 PCT/JP2022/031726 JP2022031726W WO2024042613A1 WO 2024042613 A1 WO2024042613 A1 WO 2024042613A1 JP 2022031726 W JP2022031726 W JP 2022031726W WO 2024042613 A1 WO2024042613 A1 WO 2024042613A1
Authority
WO
WIPO (PCT)
Prior art keywords
user
information
disease recurrence
terminal
risk value
Prior art date
Application number
PCT/JP2022/031726
Other languages
French (fr)
Japanese (ja)
Inventor
瑛里子 今井
Original Assignee
日本電気株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本電気株式会社 filed Critical 日本電気株式会社
Priority to PCT/JP2022/031726 priority Critical patent/WO2024042613A1/en
Publication of WO2024042613A1 publication Critical patent/WO2024042613A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Definitions

  • the present invention relates to a terminal, a terminal control method, and a storage medium.
  • Patent Document 1 describes that a device is provided that can automatically record the weight of a person who has experienced heart failure or renal failure and can notify a warning when the possibility of disease recurrence increases. .
  • Patent Document 2 describes that it is possible to analyze multiple facial images and measure body weight based on the correlation between parts that influence body weight and parts that do not.
  • Patent Document 1 simply observing changes in body weight may not be sufficient to prevent disease recurrence.
  • Patent Document 2 only discloses that body weight is measured by analyzing facial images, and has nothing to do with preventing disease recurrence.
  • the main purpose of the present invention is to provide a terminal, a terminal control method, and a storage medium that contribute to more reliably preventing disease recurrence.
  • an acquisition means for acquiring biological information of a user, an estimation means for estimating vital data based on the acquired biological information, and an estimation means for estimating vital data based on the acquired biological information;
  • a terminal comprising a calculation means for calculating a disease recurrence risk value indicating the disease recurrence risk of the user based on the above information, and a providing means for providing information according to the calculated disease recurrence risk value.
  • a terminal acquires biometric information of a user, estimates vital data based on the acquired biometric information, and estimates the vital data of the user based on the estimated vital data.
  • a method for controlling a terminal is provided, which calculates a disease recurrence risk value indicating a disease recurrence risk and provides information according to the calculated disease recurrence risk value.
  • a computer installed in a terminal is provided with a process of acquiring biometric information of a user, a process of estimating vital data based on the acquired biometric information, and a process of estimating vital data based on the acquired biometric information.
  • a computer-readable storage medium is provided for storing.
  • a terminal a terminal control method, and a storage medium are provided that contribute to more reliably preventing disease recurrence.
  • the effects of the present invention are not limited to the above. According to the present invention, other effects may be achieved instead of or in addition to the above effects.
  • FIG. 1 is a diagram for explaining an overview of one embodiment.
  • FIG. 2 is a flowchart for explaining the operation of one embodiment.
  • FIG. 3 is a diagram illustrating an example of a schematic configuration of an information processing system according to the first embodiment.
  • FIG. 4 is a diagram illustrating an example of a processing configuration of a user terminal according to the first embodiment.
  • FIG. 5 is a diagram illustrating an example of a display on a user terminal according to the first embodiment.
  • FIG. 6 is a diagram illustrating an example of the health management database according to the first embodiment.
  • FIG. 7 is a diagram showing an example of a display on a user terminal according to the first embodiment.
  • FIG. 8 is a diagram for explaining the operation of the health information providing unit according to the first embodiment.
  • FIG. 1 is a diagram for explaining an overview of one embodiment.
  • FIG. 2 is a flowchart for explaining the operation of one embodiment.
  • FIG. 3 is a diagram illustrating an example of a schematic configuration of an information processing
  • FIG. 9 is a diagram illustrating an example of a display on the supporter terminal according to the first embodiment.
  • FIG. 10 is a flowchart illustrating an example of the operation of the user terminal according to the first embodiment.
  • FIG. 11 is a diagram illustrating an example of the hardware configuration of a user terminal according to the present disclosure.
  • the terminal 100 includes an acquisition means 101, an estimation means 102, a calculation means 103, and a provision means 104 (see FIG. 1).
  • the acquisition means 101 acquires the user's biometric information (step S1 in FIG. 2).
  • the estimation means 102 estimates vital data based on the acquired biological information (step S2).
  • the calculation means 103 calculates a disease recurrence risk value indicating the user's disease recurrence risk based on the estimated vital data (step S3).
  • the providing means 104 provides information according to the calculated disease recurrence risk value (step S4).
  • the terminal 100 acquires biometric information of a user (user at risk of disease recurrence) and estimates vital data based on the acquired biometric information. For example, the terminal 100 estimates vital data such as the user's weight, blood pressure, and heart rate from biometric information.
  • the terminal 100 calculates the user's disease recurrence risk value using the estimated vital data, and provides information according to the calculated risk value. For example, if it is determined that the risk (possibility) of disease recurrence is high, the terminal 100 notifies the user or his or her supporter to that effect. That is, the terminal 100 calculates a disease recurrence risk value using not only the weight but also other vital data, and provides appropriate information to the patient or his or her supporter based on the risk value. As a result, an accurate risk of disease recurrence is calculated, and with appropriate support from supporters, disease recurrence can be more reliably prevented.
  • FIG. 3 is a diagram illustrating an example of a schematic configuration of an information processing system (information providing system) according to the first embodiment.
  • the information processing system includes a user and a supporter.
  • patients who are at risk of disease recurrence are assumed to be the main users.
  • a patient suffering from heart failure is assumed to be a user.
  • a user has a user terminal 10 such as a smartphone.
  • a user inputs various information into the user terminal 10 or obtains information from the user terminal 10.
  • Supporters support the daily lives of users with chronic illnesses. For example, a family doctor, a family member, a relative, an acquaintance, a friend, a care staff member, a welfare officer, etc. are exemplified as supporters.
  • the supporter has a supporter terminal 20 such as a smartphone.
  • the supporter inputs various information into the supporter terminal 20 or obtains information from the supporter terminal 20.
  • Users who are at risk of disease recurrence enter information regarding their daily health into an application installed on the user terminal 10. For example, a patient suffering from heart failure uses a "health management application” to input "questionnaire information" in order to prevent recurrence of heart failure.
  • the medical interview information is information necessary for a doctor to determine whether or not the user's illness will recur.
  • the interview information includes "medication information,” “subjective symptoms,” “hospital visit records,” “sleep information,” “meal information,” “exercise information,” and the like.
  • a "health notebook (heart failure notebook)" is created by the user inputting medical interview information into the user terminal 10 every day.
  • the user terminal 10 acquires the user's biometric information and estimates the user's vital data from the acquired biometric information.
  • the user terminal 10 calculates the user's disease recurrence risk using the estimated value of vital data, and provides the user and/or the supporter with information corresponding to the disease recurrence risk.
  • FIG. 4 is a diagram showing an example of a processing configuration (processing module) of the user terminal 10 according to the first embodiment.
  • the user terminal 10 includes a communication control section 201, an identity confirmation section 202, an interview information control section 203, a recurrence risk management section 204, a health information provision section 205, a storage section 206, Equipped with
  • the communication control unit 201 is a means for controlling communication with other devices. For example, the communication control unit 201 receives data (packets) from the supporter terminal 20. Furthermore, the communication control unit 201 transmits data to the supporter terminal 20. The communication control unit 201 passes data received from other devices to other processing modules. The communication control unit 201 transmits data acquired from other processing modules to other devices. In this way, other processing modules transmit and receive data to and from other devices via the communication control unit 201.
  • the communication control unit 201 has a function as a reception unit that receives data from another device, and a function as a transmission unit that transmits data to the other device.
  • the "health management application” is mainly realized by the identity verification section 202, medical interview information control section 203, recurrence risk management section 204, and health information provision section 205.
  • the identity verification unit 202 is a means for verifying the identity of the user who operates the user terminal 10.
  • the identity verification unit 202 verifies the user's identity before the user inputs medical interview information. That is, the identity verification unit 202 prevents a third party other than the individual from inputting medical interview information into the health management application.
  • the user terminal 10 stores the owner's biometric information (for example, face information, fingerprint information).
  • biometric information for example, face information, fingerprint information
  • the identity verification unit 202 acquires biometric information (for example, facial information, fingerprint information) for authenticating the user. do.
  • the identity verification unit 202 determines that identity verification has been successful if the biometric information registered in advance and the biometric information acquired at the time of starting the health management application substantially match. If the identity verification section 202 fails to verify the identity, the identity verification section 202 cancels activation of the health management application. If the identity verification is successful, the identity verification unit 202 completes activation of the health management application.
  • the identity verification unit 202 calculates the degree of similarity between feature amounts generated from facial images. If the degree of similarity is greater than or equal to the predetermined value, the identity verification unit 202 determines that identity verification has been successful.
  • the identity verification unit 202 may perform identity verification using other information instead of or in addition to biometric information.
  • the identity verification unit 202 may perform identity verification (identity authentication) using a password or the like.
  • the medical interview information control unit 203 is a means for controlling the medical interview information acquired from the user.
  • the medical interview information control unit 203 functions as an acquiring unit (obtaining means) that acquires biometric information and medical interview information of the user, and an estimating unit (estimating unit) that estimates vital data based on the acquired biological information. It has the functions of:
  • the medical interview information control unit 203 When the user's identity is successfully verified and the user performs a predetermined operation on the health management application (for example, pressing the input button for the health notebook), the medical interview information control unit 203 creates a graphical user interface (GUI) for acquiring medical interview information. Display the interface). For example, the medical interview information control unit 203 acquires medical interview information using a GUI as shown in FIG.
  • GUI graphical user interface
  • the presence or absence of "shortness of breath,” “swelling,” “easiness to get tired,” “decreased appetite,” and “insomnia” are acquired as subjective symptoms. Furthermore, whether or not exercise is performed is acquired as exercise information. Furthermore, as medication information, whether or not medication is taken during each time period of morning, noon, and evening is acquired. Note that the display shown in FIG. 5 is an example, and is not intended to limit the items to be displayed or the display mode.
  • the medical interview information control unit 203 may automatically indicate and record the date and time (year, month, day, hour, minute, and second) when the user inputs the health notebook.
  • the medical interview information control unit 203 may prepare an interface that allows users to enter each item on a large screen, rather than an interface that allows them to enter all items on one screen. Good too.
  • the medical interview information control unit 203 may support not only information input using a touch panel but also information input using voice.
  • the medical interview information control unit 203 may automatically capture input data from other wearable terminals or health applications, and automatically display the captured data.
  • the medical interview information control unit 203 stores the acquired medical interview information in the health management database (see FIG. 6).
  • the health management database shown in FIG. 6 is an example, and is not intended to limit the items to be stored.
  • the acquired biometric information of the user may be registered in a health management database.
  • the interview information control unit 203 acquires the biometric information of the user while the user is inputting the interview information (while inputting the interview information). Specifically, the interview information control unit 203 acquires image data (still image data, video data) including a facial image of the user by photographing the user who is inputting the interview information.
  • the medical interview information control unit 203 acquires, for example, approximately 30 seconds of video data.
  • the medical interview information control unit 203 Upon acquiring the user's biometric information (for example, video data obtained by photographing the user), the medical interview information control unit 203 estimates the user's vital data using the acquired biometric information.
  • biometric information for example, video data obtained by photographing the user
  • the medical interview information control unit 203 acquires estimated values of vital data such as the user's weight, heart rate, blood pressure, blood sugar level, and oxygen saturation level by analyzing the acquired biological information.
  • analysis of biological information for estimating vital data may be performed using a learning model obtained by machine learning.
  • a company developing a health management application generates a learning model using a large amount of training data consisting of a combination of video data including facial information and vital data measurement results.
  • the user's weight has a relationship with the outline of the face, etc., and a learning model that uses this relationship (a learning model that obtains the weight when a face image is input) can be generated.
  • heart rate is related to changes in facial surface brightness (facial surface brightness caused by blood flow), and a learning model that utilizes this relationship (a learning model that obtains heart rate by inputting multiple facial images) has been developed. It is possible to generate Furthermore, facial swelling can be estimated from the physical distance of facial feature points and blood flow, and a learning model for estimating facial swelling can be generated.
  • the generated learning model is installed on the user terminal 10 as part of the health management application.
  • the medical interview information control unit 203 acquires estimated values of vital data by inputting the acquired biological information (for example, video data including facial information) into the learning model.
  • the medical interview information control unit 203 stores the acquired estimated vital data values in a health management database.
  • the recurrence risk management unit 204 is a means for managing the user's disease recurrence risk.
  • the recurrence risk management unit 204 has a function as a calculation unit (calculation means) that calculates a disease recurrence risk value indicating the user's disease recurrence risk based on the estimated vital data.
  • the recurrence risk management unit 204 quantifies the risk of recurrence of the user's disease periodically or at a predetermined timing. For example, the recurrence risk management unit 204 calculates a "disease recurrence risk value" at the timing when vital data is successfully estimated from the biological information obtained when inputting medical interview information. For example, the recurrence risk management unit 204 calculates a disease recurrence risk value in 10 stages.
  • the recurrence risk management unit 204 calculates a disease recurrence risk value using the estimated vital data value.
  • the recurrence risk management unit 204 can use the learning model to calculate the disease recurrence risk value.
  • Machine learning is performed using the collected training data, and a learning model (discriminator) is generated.
  • a learning model discriminator
  • any algorithm such as support vector machine, boosting, neural network, etc. can be used to generate the learning model. It should be noted that since a well-known technique can be used for the algorithm such as the support vector machine, a description thereof will be omitted.
  • the generated learning model is installed on the user terminal 10 as part of the health management application.
  • the recurrence risk management unit 204 obtains a disease recurrence risk value by inputting the latest vital data into the learning model.
  • the recurrence risk management unit 204 may calculate the disease recurrence risk value based on the interview information input by the user. For example, the recurrence risk management unit 204 calculates a high disease recurrence risk value when medical interview information such as a cough and inability to sleep is input. In this case as well, the recurrence risk management unit 204 may calculate the disease recurrence risk value using the learning model.
  • the health management application may calculate the disease recurrence risk value based on the interview information (for example, subjective symptoms, exercise information, etc.) and the estimated vital data.
  • the recurrence risk management unit 204 may use a learning model generated using medical interview information and vital data to which a label (disease recurrence risk value) is attached.
  • the recurrence risk management unit 204 stores the calculated disease recurrence risk value in the health management database.
  • the health information providing unit 205 is a means for providing information regarding the user's health. Specifically, the health information providing unit 205 provides information according to the calculated disease recurrence risk value. For example, the health information providing unit 205 provides information regarding the user's health to at least one of the user and the user's supporter based on the disease recurrence risk value.
  • the health information providing unit 205 performs processing according to the calculated disease recurrence risk value.
  • the health information providing unit 205 accesses the health management database periodically or at a predetermined timing to obtain the latest disease recurrence risk value.
  • the health information providing unit 205 does not perform any particular operation.
  • the health information providing unit 205 notifies the person and/or the supporter of the fact that the disease recurrence risk is high.
  • the health information providing unit 205 generates health information including information regarding the user's health.
  • the health information providing unit 205 generates health information including disease recurrence risk values, estimated vital data values, interview information, and the like.
  • the health information providing unit 205 provides (notifies) the generated health information to the person and/or the supporter.
  • the health information providing unit 205 When providing health information to the user, the health information providing unit 205 displays a display as shown in FIG. 7 to notify the user of the fact that the risk of disease recurrence is increasing. At this time, the health information providing unit 205 may notify the user of the disease recurrence risk value, as shown in FIG. 7.
  • the health information providing unit 205 When providing health information to a supporter, the health information providing unit 205 sends the health information and the user's personal information (for example, A “health information notification” containing information such as name, etc.) is sent (see Figure 8).
  • the supporter terminal 20 performs display using the health information included in the received health information notification.
  • the supporter terminal 20 upon receiving the health information notification, displays a display as shown in FIG.
  • the display shown in FIG. 9 is an example, and is not intended to limit the content or display mode displayed on the supporter terminal 20.
  • the supporter terminal 20 may display data such as graphs showing time-series changes in the user's vital data (blood pressure, heart rate, etc.), medication status, etc. instead of or in addition to the disease recurrence risk value.
  • the destination of the health information notification is stored in the user terminal 10 in advance.
  • the e-mail address of a family doctor or the like is registered in the user terminal 10 as a destination for health information notifications.
  • the destination of the health information notification may be stored in a server on the network (server on the cloud), another device, or the like.
  • the user terminal 10 accesses the server on the cloud and other devices as necessary.
  • the server or other device on the cloud may verify the authority of the user terminal 10, and if there is no problem with the verification, transmit the destination of the health information notification to the user terminal 10.
  • the health information providing unit 205 notifies the user that the risk of disease recurrence is high when the disease recurrence risk value is greater than or equal to the predetermined value (first threshold).
  • the disease recurrence risk value is greater than or equal to a predetermined value (second threshold)
  • the health information providing unit 205 notifies a support person who supports the user that the risk of disease recurrence is high.
  • the first threshold value and the second threshold value may be the same value or may be different values.
  • the storage unit 206 is a means for storing information necessary for the operation of the user terminal 10.
  • the user terminal 10 verifies the identity of the user who starts the health management application (step S101).
  • the user terminal 10 acquires medical interview information from the user (step S102).
  • the user terminal 10 acquires biometric information of the user by photographing the user while inputting medical interview information (step S103). For example, the user terminal 10 acquires still image data or video data obtained by photographing a user as biometric information.
  • the user terminal 10 estimates the user's vital data using the acquired biometric information (step S104).
  • the user terminal 10 calculates a disease recurrence risk value using at least the estimated value of vital data (step S105).
  • the user terminal 10 If the risk of disease recurrence is increasing, the user terminal 10 notifies the person and/or the supporter to that effect (notification of disease recurrence risk; step S106).
  • Examples of the supporter terminal 20 include mobile terminal devices such as smartphones, mobile phones, game consoles, and tablets, computers (personal computers, notebook computers), and the like.
  • the supporter terminal 20 can be any equipment or device as long as it can accept operations from the supporter and communicate with the user terminal 10 and the like. Furthermore, since the configuration of the supporter terminal 20 is obvious to those skilled in the art, detailed explanation will be omitted.
  • the user terminal 10 acquires biometric information of a user who is at risk of disease recurrence, and estimates vital data based on the acquired biometric information.
  • the user terminal 10 calculates the user's disease recurrence risk value using the estimated vital data, and provides information according to the calculated risk value. For example, if it is determined that the risk (possibility) of disease recurrence is high, the user terminal 10 notifies the user or his or her supporter to that effect. In order to prevent the recurrence of diseases such as heart failure, it is necessary to recognize the symptoms in advance and take appropriate measures.
  • the user terminal 10 When the user terminal 10 detects signs of disease recurrence based on estimated vital data, etc., the user terminal 10 notifies the user and his/her supporters (family doctor, family, care staff, etc.) of this fact. As a result, appropriate treatment can be taken before the disease actually occurs again, and disease recurrence can be prevented.
  • FIG. 11 is a diagram showing an example of the hardware configuration of the user terminal 10.
  • the user terminal 10 can be configured by an information processing device (so-called computer), and has the configuration illustrated in FIG. 11.
  • the user terminal 10 includes a processor 311, a memory 312, an input/output interface 313, a communication interface 314, and the like.
  • the components such as the processor 311 are connected by an internal bus or the like and are configured to be able to communicate with each other.
  • the configuration shown in FIG. 11 is not intended to limit the hardware configuration of the user terminal 10.
  • the user terminal 10 may include hardware not shown, and may not include the input/output interface 313 if necessary.
  • the number of processors 311 and the like included in the user terminal 10 is not limited to the example shown in FIG. 11; for example, a plurality of processors 311 may be included in the user terminal 10.
  • the processor 311 is, for example, a programmable device such as a CPU (Central Processing Unit), an MPU (Micro Processing Unit), or a DSP (Digital Signal Processor). Alternatively, the processor 311 may be a device such as an FPGA (Field Programmable Gate Array) or an ASIC (Application Specific Integrated Circuit). The processor 311 executes various programs including an operating system (OS).
  • OS operating system
  • the memory 312 is a RAM (Random Access Memory), a ROM (Read Only Memory), an HDD (Hard Disk Drive), an SSD (Solid State Drive), or the like.
  • the memory 312 stores OS programs, application programs, and various data.
  • the input/output interface 313 is an interface for a display device or input device (not shown).
  • the display device is, for example, a liquid crystal display.
  • the input device is, for example, a device such as a keyboard or a mouse that receives user operations.
  • the communication interface 314 is a circuit, module, etc. that communicates with other devices.
  • the communication interface 314 includes a NIC (Network Interface Card).
  • the functions of the user terminal 10 are realized by various processing modules.
  • the processing module is realized, for example, by the processor 311 executing a program stored in the memory 312. Further, the program can be recorded on a computer-readable storage medium.
  • the storage medium can be non-transitory, such as a semiconductor memory, a hard disk, a magnetic recording medium, an optical recording medium, etc. That is, the present invention can also be implemented as a computer program product.
  • the above program can be updated via a network or by using a storage medium that stores the program.
  • the processing module may be realized by a semiconductor chip.
  • the user terminal 10 which is an information processing device, is equipped with a computer, and the functions of the user terminal 10 can be realized by having the computer execute a program. Further, the user terminal 10 executes the control method for the user terminal 10 using the program.
  • heart failure As an example of a disease with a risk of recurrence.
  • diseases to which the present disclosure is applicable are not limited to heart failure.
  • the present disclosure is applicable to any disease.
  • the user terminal 10 (health management application) disclosed in the present application is capable of providing information regarding not only heart failure but also recurrence or aggravation of other diseases such as circulatory diseases and diabetes.
  • identity verification is performed when starting the health management application.
  • identity verification is performed when the user terminal 10 is activated, the identity verification upon activation of the health management application may be omitted.
  • the user terminal 10 may acquire consent from the user to photograph the user. Alternatively, the user terminal 10 may display the image data being captured on the interview information input screen.
  • the user terminal 10 acquires medical interview information using a GUI as shown in FIG.
  • the interview information may be obtained by other methods.
  • the user terminal 10 may acquire medical interview information through voice input.
  • the user terminal 10 may acquire medical interview information by selecting questions or responding through a chatbot or the like.
  • the user terminal 10 acquires medical interview information from the user himself/herself using the GUI.
  • the user terminal 10 may estimate all or part of the interview information depending on the manner in which the user operates the user terminal 10 (how the user operates). For example, the user terminal 10 may estimate the presence or absence of "dementia" based on the accuracy and smoothness of character input by the user. For example, the user terminal 10 determines that the user is spending a lot of time inputting data or that the number of input errors has increased significantly based on the time required for past data input and the frequency of input errors. In some cases, the user may be presumed to be suffering from "dementia.”
  • the user terminal 10 acquires biological information (image data including a face image) necessary for estimating vital data while the user is inputting medical interview information.
  • the biometric information may be acquired not only when inputting medical interview information but also when the user is operating another application or the like.
  • the user terminal 10 may acquire biometric information while the user is using an SNS (Social Networking Service) application or browsing a WEB page.
  • SNS Social Networking Service
  • the user terminal 10 may acquire all or part of the medical interview information (for example, medication information, sleep information, etc.) from an application different from the health management application.
  • the user terminal 10 may acquire medical interview information from an application that manages medication, an application that measures the quality of sleep, or the like.
  • the user terminal 10 may notify a support person (for example, a family doctor or a family member) of this fact. Alternatively, if the user terminal 10 determines that the user has not taken the necessary medication (forgot to take the medication) based on the acquired interview information, the user terminal 10 may notify the user or a supporter (for example, a family member) to that effect. may be notified. Alternatively, if the user terminal 10 is able to obtain the user's meal contents and the user is consuming too much salt or not enough water, the user terminal 10 notifies the user or a supporter to that effect. You may.
  • a support person for example, a family doctor or a family member
  • the user may wear a terminal (so-called wearable device) that can measure blood pressure, heart rate, etc.
  • the user terminal 10 may acquire vital data from the wearable device. Specifically, the user terminal 10 may acquire vital data measured by the wearable device using short-range wireless communication means such as Bluetooth (registered trademark).
  • the user terminal 10 may use vital data acquired from a wearable device as all or part of the vital data necessary for calculating the disease recurrence risk value. That is, the user terminal 10 may calculate the disease recurrence risk value using vital data acquired from other devices (health equipment; for example, a wearable device, a scale, a blood pressure monitor).
  • the user terminal 10 may acquire image data showing not only the user's face but also the entire user as biometric information. Alternatively, the user terminal 10 may acquire image data showing part of the user's face as biometric information. For example, the user terminal 10 may acquire image data (still image data, video data) showing both eyes (pupils) of the user as biometric information.
  • the user terminal 10 may estimate vital data using the acquired whole body image data and pupil image data. For example, the user terminal 10 may estimate heart rate, breathing rate, etc. from shoulder movements, or may acquire the size (dilation) of pupils as vital data.
  • the user terminal 10 may use different biological information (still image data, video data) and learning models depending on the type of vital data to be estimated. For example, when estimating the weight, the user terminal 10 estimates the user's weight by inputting still image data (part of the video data) to a learning model dedicated to weight estimation. Alternatively, when estimating blood pressure or heart rate, the user terminal 10 inputs video data (a plurality of still image data) into a learning model dedicated to blood pressure estimation or heart rate estimation, so that the user's Estimate blood pressure and heart rate. The user terminal 10 can obtain more accurate vital data by using biological information and a learning model suitable for the vital data to be estimated. Alternatively, the user terminal 10 may acquire video data or the like suitable for the vital data to be estimated. For example, the user terminal 10 may acquire (generate) a video with a frame rate suitable for the estimated vital data.
  • the user terminal 10 may use the acquired biometric information for purposes other than estimating vital data. For example, the user terminal 10 may estimate the presence or absence of dementia, the presence or absence of a genetic disease, etc. using the acquired biological information. For example, the user terminal 10 may determine the presence or absence of dementia, the presence or absence of a genetic disease, etc. by inputting still image data including a user's face image into a learning model.
  • the user terminal 10 may estimate (generate) the interview information using the acquired biometric information. For example, the user terminal 10 may estimate "easiness to get tired” by inputting a face image into a learning model. Alternatively, the user terminal 10 may estimate the user's emotions (emotions, anger, sadness, and happiness) by inputting the acquired biological information into a learning model. That is, the user terminal 10 may estimate the user's emotions (feelings, mood) by analyzing the user's “facial expressions”. Alternatively, the user terminal 10 may use different learning models or the like depending on the age of the user.
  • the user terminal 10 may calculate the disease recurrence risk value using not only the latest vital data estimate but also the vital data estimate acquired in the past. For example, the user terminal 10 may calculate the disease recurrence risk value by inputting estimated values of vital data acquired over a predetermined period (for example, one week) into a learning model. In this case, the disease recurrence risk value is calculated by taking into account the change (rate of change) in the estimated value of vital data, so that the disease recurrence risk can be grasped more accurately. Similarly, the user terminal 10 may calculate a disease recurrence risk value using estimated values of vital data and interview information for a predetermined period.
  • the user terminal 10 does not perform any special operation (notification) when the disease recurrence risk value is lower than a predetermined value. However, if the disease recurrence risk value is low, the user terminal 10 may notify the user or the supporter of the fact that the disease recurrence risk is low.
  • the user terminal 10 may change the health information notification destination and notification content depending on the degree of disease recurrence risk. For example, if the risk of disease recurrence is extremely high (if the disease recurrence risk value is greater than a predetermined threshold), the user terminal 10 notifies the person and the support person to that effect. On the other hand, if the risk of recurrence is not so high, the user terminal 10 may limit itself to giving the person advice on how to improve his or her lifestyle.
  • the user terminal 10 sends health information to the user when the disease recurrence risk value exceeds a first threshold, and sends support to the user when the disease recurrence risk value exceeds a second threshold. You may send health information to others.
  • the health notebook (collection of medical interview information and estimated vital data) generated by the user terminal 10 may be shared with medical institutions and the like.
  • a user may operate the user terminal 10 to submit a health notebook (contents of a health management database) to a medical institution during online medical treatment.
  • the health information (disease recurrence risk value, medical interview information, estimated vital data) generated by the user terminal 10 is provided to supporters and the like.
  • the health information may also be provided to public institutions such as private companies and local governments.
  • the user terminal 10 may provide interview information and estimated values of vital data to an insurance company or retailer with the consent of the user.
  • Money may be paid to the user who provided the interview information and estimated vital data. That is, a data utilization business regarding medical interview information and estimated values of vital data may be conducted.
  • data may be provided to insurance companies for the development of insurance products, or data may be provided to retailers to promote health foods.
  • the user terminal 10 may award points to the user each time the user inputs the interview information, in order to motivate the user to input the interview information.
  • the health management database is configured inside the user terminal 10, but the database may be configured in an external database server or the like. That is, the information processing system may include a server device, and the server device may manage the health status (interview information, estimated vital data) of each user. Further, the server device may perform control regarding notification of health information (provision of health information). That is, some functions of the user terminal 10 may be implemented in another apparatus, device, or the like.
  • each device (user terminal 10, supporter terminal 20) is not particularly limited, but data transmitted and received between these devices may be encrypted.
  • personal information such as medical interview information is transmitted and received between these devices, and in order to appropriately protect this information, it is desirable that encrypted data be transmitted and received.
  • each embodiment may be used alone or in combination.
  • the terminal according to supplementary note 4 wherein the providing means notifies a supporter who supports the user that the risk of disease recurrence is high when the disease recurrence risk value is equal to or higher than a predetermined value.
  • the terminal according to supplementary note 4 further comprising an identity verification means for verifying the identity of the user before the user inputs the medical interview information.
  • the acquisition means acquires still image data or video data obtained by photographing the user as the biometric information.

Landscapes

  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

Provided is a terminal that contributes to more reliably preventing recurrence of a disease. This terminal comprises an acquisition means, an estimation means, a calculation means, and a provision means. The acquisition means acquires biometric information pertaining to a user. The estimation means estimates vital data on the basis of the acquired biological information. The calculation means calculates a disease recurrence risk value indicating a risk of disease recurrence in the user on the basis of the estimated vital data. The provision means provides information that corresponds to the calculated disease recurrence risk value.

Description

端末、端末の制御方法及び記憶媒体Terminal, terminal control method, and storage medium
 本発明は、端末、端末の制御方法及び記憶媒体に関する。 The present invention relates to a terminal, a terminal control method, and a storage medium.
 利用者の病気再発を警告する技術が存在する。 Technology exists to warn users of disease recurrence.
 例えば、特許文献1には、心不全や腎不全の発症経験者の体重を自動的に記録し、病気再発の可能性が高くなったときに警告を通知できる装置を提供する、と記載されている。 For example, Patent Document 1 describes that a device is provided that can automatically record the weight of a person who has experienced heart failure or renal failure and can notify a warning when the possibility of disease recurrence increases. .
 また、顔画像に基づいて利用者の体重を推定する技術が存在する。 Additionally, there is a technology that estimates a user's weight based on a facial image.
 例えば、特許文献2には、複数の顔画像を分析し、体重に影響する部分とそうでない部分との相関関係から体重測定を行うことを可能とする、と記載されている。 For example, Patent Document 2 describes that it is possible to analyze multiple facial images and measure body weight based on the correlation between parts that influence body weight and parts that do not.
特開2015-164502号公報Japanese Patent Application Publication No. 2015-164502 特開2017-041218号公報JP 2017-041218 Publication
 特許文献1に記載されたように、心不全の発症と体重増加には関連性がある。しかし、心不全等の病気の再発を防止するには、体重だけでなく他のバイタルデータ(例えば、血圧、心拍数)や患者の自覚症状(例えば、むくみ、息切れ等)が把握されることが必要となる。 As described in Patent Document 1, there is a relationship between the onset of heart failure and weight gain. However, in order to prevent recurrence of diseases such as heart failure, it is necessary to understand not only weight but also other vital data (e.g., blood pressure, heart rate) and the patient's subjective symptoms (e.g., swelling, shortness of breath, etc.) becomes.
 即ち、特許文献1に開示されたように、体重変化を観察するだけでは病気の再発防止には不十分な可能性がある。なお、特許文献2は、顔画像の解析により体重測定を行うことを開示することに留まり、病気再発の防止とは無関係である。 That is, as disclosed in Patent Document 1, simply observing changes in body weight may not be sufficient to prevent disease recurrence. Note that Patent Document 2 only discloses that body weight is measured by analyzing facial images, and has nothing to do with preventing disease recurrence.
 本発明は、より確実に病気再発を防止することに寄与する、端末、端末の制御方法及び記憶媒体を提供することを主たる目的とする。 The main purpose of the present invention is to provide a terminal, a terminal control method, and a storage medium that contribute to more reliably preventing disease recurrence.
 本発明の第1の視点によれば、利用者の生体情報を取得する、取得手段と、前記取得された生体情報に基づいてバイタルデータを推定する、推定手段と、前記推定されたバイタルデータに基づいて前記利用者の病気再発リスクを示す病気再発リスク値を算出する、算出手段と、前記算出された病気再発リスク値に応じた情報提供を行う、提供手段と、を備える、端末が提供される。 According to a first aspect of the present invention, there is provided an acquisition means for acquiring biological information of a user, an estimation means for estimating vital data based on the acquired biological information, and an estimation means for estimating vital data based on the acquired biological information; A terminal is provided, comprising a calculation means for calculating a disease recurrence risk value indicating the disease recurrence risk of the user based on the above information, and a providing means for providing information according to the calculated disease recurrence risk value. Ru.
 本発明の第2の視点によれば、端末において、利用者の生体情報を取得し、前記取得された生体情報に基づいてバイタルデータを推定し、前記推定されたバイタルデータに基づいて前記利用者の病気再発リスクを示す病気再発リスク値を算出し、前記算出された病気再発リスク値に応じた情報提供を行う、端末の制御方法が提供される。 According to the second aspect of the present invention, a terminal acquires biometric information of a user, estimates vital data based on the acquired biometric information, and estimates the vital data of the user based on the estimated vital data. A method for controlling a terminal is provided, which calculates a disease recurrence risk value indicating a disease recurrence risk and provides information according to the calculated disease recurrence risk value.
 本発明の第3の視点によれば、端末に搭載されたコンピュータに、利用者の生体情報を取得する処理と、前記取得された生体情報に基づいてバイタルデータを推定する処理と、前記推定されたバイタルデータに基づいて前記利用者の病気再発リスクを示す病気再発リスク値を算出する処理と、前記算出された病気再発リスク値に応じた情報提供を行う処理と、を実行させるためのプログラムを記憶する、コンピュータ読取可能な記憶媒体が提供される。 According to the third aspect of the present invention, a computer installed in a terminal is provided with a process of acquiring biometric information of a user, a process of estimating vital data based on the acquired biometric information, and a process of estimating vital data based on the acquired biometric information. A program for executing a process of calculating a disease recurrence risk value indicating the risk of disease recurrence of the user based on the vital data obtained by the user, and a process of providing information according to the calculated disease recurrence risk value. A computer-readable storage medium is provided for storing.
 本発明の各視点によれば、より確実に病気再発を防止することに寄与する、端末、端末の制御方法及び記憶媒体が提供される。なお、本発明の効果は上記に限定されない。本発明により、当該効果の代わりに、又は当該効果と共に、他の効果が奏されてもよい。 According to each aspect of the present invention, a terminal, a terminal control method, and a storage medium are provided that contribute to more reliably preventing disease recurrence. Note that the effects of the present invention are not limited to the above. According to the present invention, other effects may be achieved instead of or in addition to the above effects.
図1は、一実施形態の概要を説明するための図である。FIG. 1 is a diagram for explaining an overview of one embodiment. 図2は、一実施形態の動作を説明するためのフローチャートである。FIG. 2 is a flowchart for explaining the operation of one embodiment. 図3は、第1の実施形態に係る情報処理システムの概略構成の一例を示す図である。FIG. 3 is a diagram illustrating an example of a schematic configuration of an information processing system according to the first embodiment. 図4は、第1の実施形態に係る利用者端末の処理構成の一例を示す図である。FIG. 4 is a diagram illustrating an example of a processing configuration of a user terminal according to the first embodiment. 図5は、第1の実施形態に係る利用者端末の表示の一例を示す図である。FIG. 5 is a diagram illustrating an example of a display on a user terminal according to the first embodiment. 図6は、第1の実施形態に係る健康管理データベースの一例を示す図である。FIG. 6 is a diagram illustrating an example of the health management database according to the first embodiment. 図7は、第1の実施形態に係る利用者端末の表示の一例を示す図である。FIG. 7 is a diagram showing an example of a display on a user terminal according to the first embodiment. 図8は、第1の実施形態に係る健康情報提供部の動作を説明するための図である。FIG. 8 is a diagram for explaining the operation of the health information providing unit according to the first embodiment. 図9は、第1の実施形態に係る支援者端末の表示の一例を示す図である。FIG. 9 is a diagram illustrating an example of a display on the supporter terminal according to the first embodiment. 図10は、第1の実施形態に係る利用者端末の動作の一例を示すフローチャートである。FIG. 10 is a flowchart illustrating an example of the operation of the user terminal according to the first embodiment. 図11は、本願開示に係る利用者端末のハードウェア構成の一例を示す図である。FIG. 11 is a diagram illustrating an example of the hardware configuration of a user terminal according to the present disclosure.
 はじめに、一実施形態の概要について説明する。なお、この概要に付記した図面参照符号は、理解を助けるための一例として各要素に便宜上付記したものであり、この概要の記載はなんらの限定を意図するものではない。また、特段の釈明がない場合には、各図面に記載されたブロックはハードウェア単位の構成ではなく、機能単位の構成を表す。各図におけるブロック間の接続線は、双方向及び単方向の双方を含む。一方向矢印については、主たる信号(データ)の流れを模式的に示すものであり、双方向性を排除するものではない。なお、本明細書及び図面において、同様に説明されることが可能な要素については、同一の符号を付することにより重複説明が省略され得る。 First, an overview of one embodiment will be explained. Note that the drawing reference numerals added to this summary are added to each element for convenience as an example to aid understanding, and the description of this summary is not intended to be limiting in any way. Furthermore, unless otherwise specified, the blocks depicted in each drawing represent the configuration of functional units rather than the configuration of hardware units. Connection lines between blocks in each figure include both bidirectional and unidirectional connections. The unidirectional arrows schematically indicate the main signal (data) flow, and do not exclude bidirectionality. Note that, in this specification and the drawings, elements that can be explained in the same manner may be designated by the same reference numerals, so that redundant explanation can be omitted.
 一実施形態に係る端末100は、取得手段101と、推定手段102と、算出手段103と、提供手段104と、を備える(図1参照)。取得手段101は、利用者の生体情報を取得する(図2のステップS1)。推定手段102は、取得された生体情報に基づいてバイタルデータを推定する(ステップS2)。算出手段103は、推定されたバイタルデータに基づいて利用者の病気再発リスクを示す病気再発リスク値を算出する(ステップS3)。提供手段104は、算出された病気再発リスク値に応じた情報提供を行う(ステップS4)。 The terminal 100 according to one embodiment includes an acquisition means 101, an estimation means 102, a calculation means 103, and a provision means 104 (see FIG. 1). The acquisition means 101 acquires the user's biometric information (step S1 in FIG. 2). The estimation means 102 estimates vital data based on the acquired biological information (step S2). The calculation means 103 calculates a disease recurrence risk value indicating the user's disease recurrence risk based on the estimated vital data (step S3). The providing means 104 provides information according to the calculated disease recurrence risk value (step S4).
 端末100は、利用者(病気再発のリスクがある利用者)の生体情報を取得し、当該取得した生体情報に基づいてバイタルデータを推定する。例えば、端末100は、利用者の体重、血圧、心拍数等のバイタルデータを生体情報から推定する。端末100は、推定したバイタルデータを用いて利用者の病気再発リスク値を算出し、当該算出されたリスク値に応じた情報提供を行う。例えば、端末100は、病気再発のリスク(可能性)が高いと判断される場合には、利用者本人又はその支援者にその旨を通知する。即ち、端末100は、体重だけでなく他のバイタルデータを用いて病気再発リスク値を算出し、当該リスク値に基づいて本人又はその支援者に適切な情報提供を行う。その結果、正確な病気再発リスクが算出されると共に、支援者による適切な支援により、より確実に病気の再発が防止される。 The terminal 100 acquires biometric information of a user (user at risk of disease recurrence) and estimates vital data based on the acquired biometric information. For example, the terminal 100 estimates vital data such as the user's weight, blood pressure, and heart rate from biometric information. The terminal 100 calculates the user's disease recurrence risk value using the estimated vital data, and provides information according to the calculated risk value. For example, if it is determined that the risk (possibility) of disease recurrence is high, the terminal 100 notifies the user or his or her supporter to that effect. That is, the terminal 100 calculates a disease recurrence risk value using not only the weight but also other vital data, and provides appropriate information to the patient or his or her supporter based on the risk value. As a result, an accurate risk of disease recurrence is calculated, and with appropriate support from supporters, disease recurrence can be more reliably prevented.
 以下に具体的な実施形態について、図面を参照してさらに詳しく説明する。 Specific embodiments will be described in more detail below with reference to the drawings.
[第1の実施形態]
 第1の実施形態について、図面を用いてより詳細に説明する。
[First embodiment]
The first embodiment will be described in more detail using the drawings.
[システムの概略]
 図3は、第1の実施形態に係る情報処理システム(情報提供システム)の概略構成の一例を示す図である。図3に示すように、情報処理システムには、利用者と、支援者と、が含まれる。
[System overview]
FIG. 3 is a diagram illustrating an example of a schematic configuration of an information processing system (information providing system) according to the first embodiment. As shown in FIG. 3, the information processing system includes a user and a supporter.
 本願開示において、病気の再発リスクがある患者が主な利用者として想定される。例えば、心不全に罹患した患者が利用者として想定される。利用者は、スマートフォン等の利用者端末10を所持する。利用者は、当該利用者端末10に種々の情報を入力したり、当該利用者端末10から情報を取得したりする。 In the present disclosure, patients who are at risk of disease recurrence are assumed to be the main users. For example, a patient suffering from heart failure is assumed to be a user. A user has a user terminal 10 such as a smartphone. A user inputs various information into the user terminal 10 or obtains information from the user terminal 10.
 支援者は、持病を持つ利用者の日常生活等を支援する。例えば、かかりつけ医、家族、親戚、知人、友人、介護スタッフ、民生委員等が支援者として例示される。支援者は、スマートフォン等の支援者端末20を所持する。支援者は、支援者端末20に種々の情報を入力したり、支援者端末20から情報を取得したりする。 Supporters support the daily lives of users with chronic illnesses. For example, a family doctor, a family member, a relative, an acquaintance, a friend, a care staff member, a welfare officer, etc. are exemplified as supporters. The supporter has a supporter terminal 20 such as a smartphone. The supporter inputs various information into the supporter terminal 20 or obtains information from the supporter terminal 20.
 病気再発の可能性がある利用者は、利用者端末10にインストールされたアプリケーションに、日々の健康に関する情報入力を行う。例えば、心不全に罹患した患者は、心不全の再発防止のために「健康管理アプリケーション」を用いて「問診情報」を入力する。 Users who are at risk of disease recurrence enter information regarding their daily health into an application installed on the user terminal 10. For example, a patient suffering from heart failure uses a "health management application" to input "questionnaire information" in order to prevent recurrence of heart failure.
 問診情報は、医師が、利用者の病気が再発するか否か判断するために必要な情報である。例えば、問診情報には、「服薬情報」、「自覚症状」、「通院記録」、「睡眠情報」、「食事情報」、「運動情報」等が含まれる。 The medical interview information is information necessary for a doctor to determine whether or not the user's illness will recur. For example, the interview information includes "medication information," "subjective symptoms," "hospital visit records," "sleep information," "meal information," "exercise information," and the like.
 利用者が日々、問診情報を利用者端末10に入力することで、「健康手帳(心不全手帳)」が作成される。 A "health notebook (heart failure notebook)" is created by the user inputting medical interview information into the user terminal 10 every day.
 また、利用者端末10は、利用者の生体情報を取得し、当該取得した生体情報から利用者のバイタルデータを推定する。利用者端末10は、バイタルデータの推定値を用いて利用者の病気再発リスクを算出し、当該病気再発リスクに応じた情報を本人及び/又は支援者に提供する。 Additionally, the user terminal 10 acquires the user's biometric information and estimates the user's vital data from the acquired biometric information. The user terminal 10 calculates the user's disease recurrence risk using the estimated value of vital data, and provides the user and/or the supporter with information corresponding to the disease recurrence risk.
[利用者端末]
 図4は、第1の実施形態に係る利用者端末10の処理構成(処理モジュール)の一例を示す図である。図4を参照すると、利用者端末10は、通信制御部201と、本人確認部202と、問診情報制御部203と、再発リスク管理部204と、健康情報提供部205と、記憶部206と、を備える。
[User terminal]
FIG. 4 is a diagram showing an example of a processing configuration (processing module) of the user terminal 10 according to the first embodiment. Referring to FIG. 4, the user terminal 10 includes a communication control section 201, an identity confirmation section 202, an interview information control section 203, a recurrence risk management section 204, a health information provision section 205, a storage section 206, Equipped with
 通信制御部201は、他の装置との間の通信を制御する手段である。例えば、通信制御部201は、支援者端末20からデータ(パケット)を受信する。また、通信制御部201は、支援者端末20に向けてデータを送信する。通信制御部201は、他の装置から受信したデータを他の処理モジュールに引き渡す。通信制御部201は、他の処理モジュールから取得したデータを他の装置に向けて送信する。このように、他の処理モジュールは、通信制御部201を介して他の装置とデータの送受信を行う。通信制御部201は、他の装置からデータを受信する受信部としての機能と、他の装置に向けてデータを送信する送信部としての機能と、を備える。 The communication control unit 201 is a means for controlling communication with other devices. For example, the communication control unit 201 receives data (packets) from the supporter terminal 20. Furthermore, the communication control unit 201 transmits data to the supporter terminal 20. The communication control unit 201 passes data received from other devices to other processing modules. The communication control unit 201 transmits data acquired from other processing modules to other devices. In this way, other processing modules transmit and receive data to and from other devices via the communication control unit 201. The communication control unit 201 has a function as a reception unit that receives data from another device, and a function as a transmission unit that transmits data to the other device.
 利用者端末10を構成する処理モジュールのうち、主に本人確認部202、問診情報制御部203、再発リスク管理部204及び健康情報提供部205により「健康管理アプリケーション」が実現される。 Among the processing modules that make up the user terminal 10, the "health management application" is mainly realized by the identity verification section 202, medical interview information control section 203, recurrence risk management section 204, and health information provision section 205.
 本人確認部202は、利用者端末10を操作する利用者の本人確認を行う手段である。本人確認部202は、利用者が問診情報を入力する前に、利用者の本人確認を行う。即ち、本人確認部202は、本人以外の第三者が問診情報を健康管理アプリケーションに入力することを防止する。 The identity verification unit 202 is a means for verifying the identity of the user who operates the user terminal 10. The identity verification unit 202 verifies the user's identity before the user inputs medical interview information. That is, the identity verification unit 202 prevents a third party other than the individual from inputting medical interview information into the health management application.
 利用者端末10は、所有者の生体情報(例えば、顔情報、指紋情報)を記憶している。本人確認部202は、利用者が健康管理アプリケーションを起動する動作(例えば、対応するアイコンをクリック)を行うと、当該利用者を認証するための生体情報(例えば、顔情報、指紋情報)を取得する。 The user terminal 10 stores the owner's biometric information (for example, face information, fingerprint information). When a user performs an action to start a health management application (for example, by clicking a corresponding icon), the identity verification unit 202 acquires biometric information (for example, facial information, fingerprint information) for authenticating the user. do.
 本人確認部202は、事前に登録された生体情報と健康管理アプリケーションの起動時に取得した生体情報が実質的に一致すれば、本人確認に成功したと判断する。本人確認部202は、本人確認に失敗すると、健康管理アプリケーションの起動を中止する。本人確認に成功すると、本人確認部202は、健康管理アプリケーションの起動を完了する。 The identity verification unit 202 determines that identity verification has been successful if the biometric information registered in advance and the biometric information acquired at the time of starting the health management application substantially match. If the identity verification section 202 fails to verify the identity, the identity verification section 202 cancels activation of the health management application. If the identity verification is successful, the identity verification unit 202 completes activation of the health management application.
 なお、生体情報を利用した本人確認は、当業者にとって明らかであるので詳細な説明を省略する。例えば、本人確認部202は、顔画像から生成された特徴量同士の類似度を計算する。類似度が所定値以上であれば、本人確認部202は、本人確認に成功したと判定する。 Note that the identity verification using biometric information is obvious to those skilled in the art, so a detailed explanation will be omitted. For example, the identity verification unit 202 calculates the degree of similarity between feature amounts generated from facial images. If the degree of similarity is greater than or equal to the predetermined value, the identity verification unit 202 determines that identity verification has been successful.
 なお、本人確認部202は、生体情報に変えて又は加えて他の情報を用いて本人確認を行ってもよい。例えば、本人確認部202は、パスワード等を用いて本人確認(本人認証)を行ってもよい。 Note that the identity verification unit 202 may perform identity verification using other information instead of or in addition to biometric information. For example, the identity verification unit 202 may perform identity verification (identity authentication) using a password or the like.
 問診情報制御部203は、利用者から取得する問診情報に関する制御を行う手段である。問診情報制御部203は、利用者の生体情報や問診情報を取得する、取得部(取得手段)としての機能と、取得された生体情報に基づいてバイタルデータを推定する、推定部(推定手段)としての機能と、を備える。 The medical interview information control unit 203 is a means for controlling the medical interview information acquired from the user. The medical interview information control unit 203 functions as an acquiring unit (obtaining means) that acquires biometric information and medical interview information of the user, and an estimating unit (estimating unit) that estimates vital data based on the acquired biological information. It has the functions of:
 利用者の本人確認に成功し、健康管理アプリケーション上で所定の動作(例えば、健康手帳の入力ボタンの押下)を行うと、問診情報制御部203は、問診情報を取得するためのGUI(Graphical User Interface)を表示する。例えば、問診情報制御部203は、図5に示すようなGUIを用いて問診情報を取得する。 When the user's identity is successfully verified and the user performs a predetermined operation on the health management application (for example, pressing the input button for the health notebook), the medical interview information control unit 203 creates a graphical user interface (GUI) for acquiring medical interview information. Display the interface). For example, the medical interview information control unit 203 acquires medical interview information using a GUI as shown in FIG.
 図5の例では、自覚症状として「息切れ」、「むくみ」、「疲れやすさ」、「食欲低下」、「不眠」の有無が取得される。また、運動情報として運動実施の有無が取得される。さらに、服薬情報として、朝昼夕の各時間帯における服薬の有無が取得される。なお、図5に示す表示は例示であって、表示する項目や表示態様等を限定する趣旨ではない。例えば、問診情報制御部203は、利用者が健康手帳を入力している日時(年月日、時分秒)を自動的に表記し、記録してもよい。あるいは、利用者が高齢であることも多いことを考慮し、問診情報制御部203は、一画面で全ての項目を入力するインターフェイスではなく、大きな画面で一項目ごとに入力するインターフェイスを用意してもよい。あるいは、問診情報制御部203は、タッチパネルを用いた情報入力だけでなく、音声による情報入力に対応していてもよい。あるいは、問診情報制御部203は、他のウェアラブル端末や健康アプリケーションからの入力データを自動的に取り込み、当該取り込んだデータを自動的に表示してもよい。 In the example of FIG. 5, the presence or absence of "shortness of breath," "swelling," "easiness to get tired," "decreased appetite," and "insomnia" are acquired as subjective symptoms. Furthermore, whether or not exercise is performed is acquired as exercise information. Furthermore, as medication information, whether or not medication is taken during each time period of morning, noon, and evening is acquired. Note that the display shown in FIG. 5 is an example, and is not intended to limit the items to be displayed or the display mode. For example, the medical interview information control unit 203 may automatically indicate and record the date and time (year, month, day, hour, minute, and second) when the user inputs the health notebook. Alternatively, considering that the users are often elderly, the medical interview information control unit 203 may prepare an interface that allows users to enter each item on a large screen, rather than an interface that allows them to enter all items on one screen. Good too. Alternatively, the medical interview information control unit 203 may support not only information input using a touch panel but also information input using voice. Alternatively, the medical interview information control unit 203 may automatically capture input data from other wearable terminals or health applications, and automatically display the captured data.
 問診情報制御部203は、取得した問診情報を健康管理データベースに記憶する(図6参照)。なお、図6に示す健康管理データベースは例示であって、記憶する項目等を限定する趣旨ではない。例えば、取得された利用者の生体情報が健康管理データベースに登録されていてもよい。 The medical interview information control unit 203 stores the acquired medical interview information in the health management database (see FIG. 6). Note that the health management database shown in FIG. 6 is an example, and is not intended to limit the items to be stored. For example, the acquired biometric information of the user may be registered in a health management database.
 問診情報制御部203は、利用者が問診情報を入力している間に(問診情報の入力中に)、当該利用者の生体情報を取得する。具体的には、問診情報制御部203は、問診情報を入力中の利用者を撮影することで、当該利用者の顔画像を含む画像データ(静止画データ、動画データ)を取得する。 The interview information control unit 203 acquires the biometric information of the user while the user is inputting the interview information (while inputting the interview information). Specifically, the interview information control unit 203 acquires image data (still image data, video data) including a facial image of the user by photographing the user who is inputting the interview information.
 問診情報制御部203は、動画データを取得する場合には、例えば、30秒程度の動画データを取得する。 When acquiring video data, the medical interview information control unit 203 acquires, for example, approximately 30 seconds of video data.
 利用者の生体情報(例えば、利用者を撮影することで得られた動画データ)を取得すると、問診情報制御部203は、取得した生体情報を用いて当該利用者のバイタルデータを推定する。 Upon acquiring the user's biometric information (for example, video data obtained by photographing the user), the medical interview information control unit 203 estimates the user's vital data using the acquired biometric information.
 例えば、問診情報制御部203は、取得した生体情報を解析することで、利用者の体重、心拍数、血圧、血糖値、酸素飽和度等のバイタルデータの推定値を取得する。 For example, the medical interview information control unit 203 acquires estimated values of vital data such as the user's weight, heart rate, blood pressure, blood sugar level, and oxygen saturation level by analyzing the acquired biological information.
 なお、バイタルデータを推定するための生体情報(顔情報を含む動画データ)の解析は、機械学習により得られる学習モデルにより行われてもよい。例えば、健康管理アプリケーションの開発企業等は、顔情報を含む動画データとバイタルデータ測定結果の組み合わせからなる多数の教師データを用いて学習モデルを生成する。 Note that analysis of biological information (video data including facial information) for estimating vital data may be performed using a learning model obtained by machine learning. For example, a company developing a health management application generates a learning model using a large amount of training data consisting of a combination of video data including facial information and vital data measurement results.
 例えば、利用者の体重は顔の輪郭等と関係があり、当該関係を利用した学習モデル(顔画像を入力すると体重が得られる学習モデル)が生成可能である。また、心拍数は顔表面の輝度(血流から生じる顔表面の輝度)の変化と関係があり、当該関係を利用した学習モデル(複数の顔画像を入力すると心拍数が得られる学習モデル)が生成可能である。さらに、顔のむくみは、顔の特徴点の物理的距離や血流量から推定可能であって、顔のむくみを推定する学習モデルが生成可能である。 For example, the user's weight has a relationship with the outline of the face, etc., and a learning model that uses this relationship (a learning model that obtains the weight when a face image is input) can be generated. In addition, heart rate is related to changes in facial surface brightness (facial surface brightness caused by blood flow), and a learning model that utilizes this relationship (a learning model that obtains heart rate by inputting multiple facial images) has been developed. It is possible to generate Furthermore, facial swelling can be estimated from the physical distance of facial feature points and blood flow, and a learning model for estimating facial swelling can be generated.
 生成された学習モデルは、健康管理アプリケーションの一部として利用者端末10に実装される。 The generated learning model is installed on the user terminal 10 as part of the health management application.
 問診情報制御部203は、取得した生体情報(例えば、顔情報を含む動画データ)を当該学習モデルに入力することで、バイタルデータの推定値を取得する。問診情報制御部203は、取得したバイタルデータ推定値を健康管理データベースに記憶する。 The medical interview information control unit 203 acquires estimated values of vital data by inputting the acquired biological information (for example, video data including facial information) into the learning model. The medical interview information control unit 203 stores the acquired estimated vital data values in a health management database.
 再発リスク管理部204は、利用者の病気再発リスクに関する管理を行う手段である。再発リスク管理部204は、推定されたバイタルデータに基づいて利用者の病気再発リスクを示す病気再発リスク値を算出する、算出部(算出手段)としての機能を備える。 The recurrence risk management unit 204 is a means for managing the user's disease recurrence risk. The recurrence risk management unit 204 has a function as a calculation unit (calculation means) that calculates a disease recurrence risk value indicating the user's disease recurrence risk based on the estimated vital data.
 再発リスク管理部204は、定期的又は所定のタイミングで、利用者の病気が再発するリスクを数値化する。例えば、再発リスク管理部204は、問診情報の入力時に得られた生体情報からバイタルデータの推定に成功したタイミングで、「病気再発リスク値」を算出する。例えば、再発リスク管理部204は、10段階の病気再発リスク値を計算する。 The recurrence risk management unit 204 quantifies the risk of recurrence of the user's disease periodically or at a predetermined timing. For example, the recurrence risk management unit 204 calculates a "disease recurrence risk value" at the timing when vital data is successfully estimated from the biological information obtained when inputting medical interview information. For example, the recurrence risk management unit 204 calculates a disease recurrence risk value in 10 stages.
 例えば、再発リスク管理部204は、バイタルデータ推定値を用いて病気再発リスク値を算出する。再発リスク管理部204は、当該病気再発リスク値の算出に学習モデルを使用することができる。 For example, the recurrence risk management unit 204 calculates a disease recurrence risk value using the estimated vital data value. The recurrence risk management unit 204 can use the learning model to calculate the disease recurrence risk value.
 健康管理アプリケーションの開発企業等は、病気再発リスク値がラベルとして付与された大量のバイタルデータ(又は、複数のバイタルデータによる組み合わせ)を教師データとして用意する。健康管理アプリケーションの開発企業等は、専門的知見を持ち合わせた医師等と協力して上記教師データを収集する。 Companies developing health management applications prepare a large amount of vital data (or a combination of multiple vital data) labeled with disease recurrence risk values as training data. Companies developing health management applications collect the above teacher data in cooperation with doctors and others with specialized knowledge.
 収集された教師データを用いた機械学習が行われ、学習モデル(識別器)が生成される。なお、学習モデルの生成には、サポートベクタマシン、ブースティングやニューラルネットワーク等の任意のアルゴリズムを用いることができる。なお、上記サポートベクタマシン等のアルゴリズムは公知の技術を使用することができるので、その説明を省略する。 Machine learning is performed using the collected training data, and a learning model (discriminator) is generated. Note that any algorithm such as support vector machine, boosting, neural network, etc. can be used to generate the learning model. It should be noted that since a well-known technique can be used for the algorithm such as the support vector machine, a description thereof will be omitted.
 生成された学習モデルは、健康管理アプリケーションの一部として利用者端末10に実装される。 The generated learning model is installed on the user terminal 10 as part of the health management application.
 再発リスク管理部204は、最新のバイタルデータを学習モデルに入力することで、病気再発リスク値を取得する。 The recurrence risk management unit 204 obtains a disease recurrence risk value by inputting the latest vital data into the learning model.
 あるいは、再発リスク管理部204は、利用者が入力した問診情報に基づいて病気再発リスク値を算出してもよい。例えば、再発リスク管理部204は、咳が出て眠れない等の問診情報が入力されている場合には、病気再発リスク値を高く算出する。この場合にも、再発リスク管理部204は、学習モデルを用いて病気再発リスク値を算出してもよい。 Alternatively, the recurrence risk management unit 204 may calculate the disease recurrence risk value based on the interview information input by the user. For example, the recurrence risk management unit 204 calculates a high disease recurrence risk value when medical interview information such as a cough and inability to sleep is input. In this case as well, the recurrence risk management unit 204 may calculate the disease recurrence risk value using the learning model.
 あるいは、健康管理アプリケーション(再発リスク管理部204)は、問診情報(例えば、自覚症状、運動情報等)とバイタルデータ推定値に基づいて病気再発リスク値を算出してもよい。この場合、再発リスク管理部204は、ラベル(病気再発リスク値)が付与された問診情報とバイタルデータを用いて生成された学習モデルを使用すればよい。 Alternatively, the health management application (recurrence risk management unit 204) may calculate the disease recurrence risk value based on the interview information (for example, subjective symptoms, exercise information, etc.) and the estimated vital data. In this case, the recurrence risk management unit 204 may use a learning model generated using medical interview information and vital data to which a label (disease recurrence risk value) is attached.
 再発リスク管理部204は、算出された病気再発リスク値を健康管理データベースに記憶する。 The recurrence risk management unit 204 stores the calculated disease recurrence risk value in the health management database.
 健康情報提供部205は、利用者の健康に関する情報を提供する手段である。具体的には、健康情報提供部205は、算出された病気再発リスク値に応じた情報提供を行う。例えば、健康情報提供部205は、病気再発リスク値に基づいて、利用者及び利用者の支援者のうち少なくとも一方に利用者の健康に関する情報を提供する。 The health information providing unit 205 is a means for providing information regarding the user's health. Specifically, the health information providing unit 205 provides information according to the calculated disease recurrence risk value. For example, the health information providing unit 205 provides information regarding the user's health to at least one of the user and the user's supporter based on the disease recurrence risk value.
 健康情報提供部205は、算出された病気再発リスク値に応じた処理を行う。健康情報提供部205は、定期的又は所定のタイミングで、健康管理データベースにアクセスし、最新の病気再発リスク値を取得する。 The health information providing unit 205 performs processing according to the calculated disease recurrence risk value. The health information providing unit 205 accesses the health management database periodically or at a predetermined timing to obtain the latest disease recurrence risk value.
 例えば、病気再発リスク値が所定値よりも低い場合には、健康情報提供部205は、特段の動作を行わない。 For example, if the disease recurrence risk value is lower than a predetermined value, the health information providing unit 205 does not perform any particular operation.
 病気再発リスク値が所定値以上の場合には、健康情報提供部205は、病気再発リスクが高い事実を本人及び/又は支援者に通知する。 If the disease recurrence risk value is greater than or equal to a predetermined value, the health information providing unit 205 notifies the person and/or the supporter of the fact that the disease recurrence risk is high.
 具体的には、健康情報提供部205は、利用者の健康に関する情報を含む健康情報を生成する。例えば、健康情報提供部205は、病気再発リスク値、バイタルデータ推定値、問診情報等を含む健康情報を生成する。 Specifically, the health information providing unit 205 generates health information including information regarding the user's health. For example, the health information providing unit 205 generates health information including disease recurrence risk values, estimated vital data values, interview information, and the like.
 健康情報提供部205は、当該生成された健康情報を本人及び/又は支援者に提供(通知)する。 The health information providing unit 205 provides (notifies) the generated health information to the person and/or the supporter.
 健康情報を本人に提供する場合には、健康情報提供部205は、図7に示すような表示を行い、利用者本人に対して病気再発リスクが高まっている事実を通知する。その際、健康情報提供部205は、図7に示すように、病気再発リスク値を利用者本人に通知してもよい。 When providing health information to the user, the health information providing unit 205 displays a display as shown in FIG. 7 to notify the user of the fact that the risk of disease recurrence is increasing. At this time, the health information providing unit 205 may notify the user of the disease recurrence risk value, as shown in FIG. 7.
 健康情報を支援者に提供する場合には、健康情報提供部205は、支援者(例えば、かかりつけ医、家族、介護スタッフ等)の支援者端末20に健康情報や利用者の個人情報(例えば、氏名等)を含む「健康情報通知」を送信する(図8参照)。支援者端末20は、受信した健康情報通知に含まれる健康情報等を用いた表示を行う。 When providing health information to a supporter, the health information providing unit 205 sends the health information and the user's personal information (for example, A “health information notification” containing information such as name, etc.) is sent (see Figure 8). The supporter terminal 20 performs display using the health information included in the received health information notification.
 例えば、健康情報通知を受信することで、支援者端末20は、図9に示すような表示を行う。なお、図9に示す表示は例示であって、支援者端末20に表示する内容や表示態様等を限定する趣旨ではない。例えば、支援者端末20は、利用者のバイタルデータ(血圧、心拍数等)の時系列変化を示すグラフや服薬状況等のデータを病気再発リスク値に代えて又は加えて表示してもよい。 For example, upon receiving the health information notification, the supporter terminal 20 displays a display as shown in FIG. Note that the display shown in FIG. 9 is an example, and is not intended to limit the content or display mode displayed on the supporter terminal 20. For example, the supporter terminal 20 may display data such as graphs showing time-series changes in the user's vital data (blood pressure, heart rate, etc.), medication status, etc. instead of or in addition to the disease recurrence risk value.
 なお、健康情報通知の送信先は予め利用者端末10に記憶されている。例えば、かかりつけ医等のメールアドレスが健康情報通知の送信先として利用者端末10に登録されている。利用者が支援者の連絡先を利用者端末10に登録することで、当該支援者に情報提供が行われることについての同意(利用者の同意)が得られたと扱われる。あるいは、健康情報通知の送信先はネットワーク上のサーバ(クラウド上のサーバ)や他のデバイス等に格納されていてもよい。利用者端末10は、必要に応じて当該クラウド上のサーバや他のデバイスにアクセスする。クラウド上のサーバや他のデバイスは、利用者端末10の権限等を検証し、当該検証に問題がなければ利用者端末10に健康情報通知の送信先を送信してもよい。 Note that the destination of the health information notification is stored in the user terminal 10 in advance. For example, the e-mail address of a family doctor or the like is registered in the user terminal 10 as a destination for health information notifications. When a user registers the contact information of a supporter in the user terminal 10, it is treated as consent (user consent) for information to be provided to the supporter. Alternatively, the destination of the health information notification may be stored in a server on the network (server on the cloud), another device, or the like. The user terminal 10 accesses the server on the cloud and other devices as necessary. The server or other device on the cloud may verify the authority of the user terminal 10, and if there is no problem with the verification, transmit the destination of the health information notification to the user terminal 10.
 このように、健康情報提供部205は、病気再発リスク値が所定値(第1の閾値)以上の場合、利用者本人に対して病気再発のリスクが高いことを通知する。あるいは、健康情報提供部205は、病気再発リスク値が所定値(第2の閾値)以上の場合、利用者を支援する支援者に対して病気再発のリスクが高いことを通知する。なお、上記第1の閾値と第2の閾値は同じ値であってもよいし、異なる値であってもよい。 In this manner, the health information providing unit 205 notifies the user that the risk of disease recurrence is high when the disease recurrence risk value is greater than or equal to the predetermined value (first threshold). Alternatively, when the disease recurrence risk value is greater than or equal to a predetermined value (second threshold), the health information providing unit 205 notifies a support person who supports the user that the risk of disease recurrence is high. Note that the first threshold value and the second threshold value may be the same value or may be different values.
 記憶部206は、利用者端末10の動作に必要な情報を記憶する手段である。 The storage unit 206 is a means for storing information necessary for the operation of the user terminal 10.
 上記説明した利用者端末10の動作をまとめると図10に示すフローチャートのとおりとなる。 The operation of the user terminal 10 described above can be summarized as shown in the flowchart shown in FIG.
 はじめに、利用者端末10は、健康管理アプリケーションを起動する利用者の本人確認を行う(ステップS101)。 First, the user terminal 10 verifies the identity of the user who starts the health management application (step S101).
 本人確認に成功すると、利用者端末10は、当該利用者から問診情報を取得する(ステップS102)。 If the identity verification is successful, the user terminal 10 acquires medical interview information from the user (step S102).
 利用者端末10は、問診情報を入力中の利用者を撮影することで、当該利用者の生体情報を取得する(ステップS103)。例えば、利用者端末10は、利用者を撮影することで得られる静止画データ又は動画データを生体情報として取得する。 The user terminal 10 acquires biometric information of the user by photographing the user while inputting medical interview information (step S103). For example, the user terminal 10 acquires still image data or video data obtained by photographing a user as biometric information.
 利用者端末10は、取得した生体情報を用いて利用者のバイタルデータを推定する(ステップS104)。 The user terminal 10 estimates the user's vital data using the acquired biometric information (step S104).
 利用者端末10は、少なくともバイタルデータの推定値を用いて病気再発リスク値を算出する(ステップS105)。 The user terminal 10 calculates a disease recurrence risk value using at least the estimated value of vital data (step S105).
 病気再発のリスクが高まっていれば、利用者端末10は、その旨を本人及び/又は支援者に通知する(病気再発リスクの通知;ステップS106)。 If the risk of disease recurrence is increasing, the user terminal 10 notifies the person and/or the supporter to that effect (notification of disease recurrence risk; step S106).
[支援者端末]
 支援者端末20には、スマートフォン、携帯電話機、ゲーム機、タブレット等の携帯端末装置やコンピュータ(パーソナルコンピュータ、ノートパソコン)等が例示される。支援者端末20は、支援者の操作を受け付け、利用者端末10等と通信可能であれば任意の機器、デバイスとすることができる。また、支援者端末20の構成等は当業者にとって明らかであるので、詳細な説明を省略する。
[Supporter terminal]
Examples of the supporter terminal 20 include mobile terminal devices such as smartphones, mobile phones, game consoles, and tablets, computers (personal computers, notebook computers), and the like. The supporter terminal 20 can be any equipment or device as long as it can accept operations from the supporter and communicate with the user terminal 10 and the like. Furthermore, since the configuration of the supporter terminal 20 is obvious to those skilled in the art, detailed explanation will be omitted.
 以上のように、第1の実施形態に係る利用者端末10は、病気再発のリスクがある利用者の生体情報を取得し、当該取得した生体情報に基づいてバイタルデータを推定する。利用者端末10は、推定したバイタルデータを用いて利用者の病気再発リスク値を算出し、当該算出されたリスク値に応じた情報提供を行う。例えば、利用者端末10は、病気再発のリスク(可能性)が高いと判断される場合には、利用者本人又はその支援者にその旨を通知する。心不全等の病気の再発を防止するためには、事前にその兆候が把握され、適切な処置が施されることが必要である。利用者端末10は、バイタルデータの推定値等から病気再発の兆候が認められた場合、利用者本人や支援者(かかりつけ医、家族、介護スタッフ等)に当該事実を通知する。その結果、実際に病気が再発する前に適切な処置が施され、病気再発が防止される。 As described above, the user terminal 10 according to the first embodiment acquires biometric information of a user who is at risk of disease recurrence, and estimates vital data based on the acquired biometric information. The user terminal 10 calculates the user's disease recurrence risk value using the estimated vital data, and provides information according to the calculated risk value. For example, if it is determined that the risk (possibility) of disease recurrence is high, the user terminal 10 notifies the user or his or her supporter to that effect. In order to prevent the recurrence of diseases such as heart failure, it is necessary to recognize the symptoms in advance and take appropriate measures. When the user terminal 10 detects signs of disease recurrence based on estimated vital data, etc., the user terminal 10 notifies the user and his/her supporters (family doctor, family, care staff, etc.) of this fact. As a result, appropriate treatment can be taken before the disease actually occurs again, and disease recurrence can be prevented.
 続いて、利用者端末10のハードウェアについて説明する。図11は、利用者端末10のハードウェア構成の一例を示す図である。 Next, the hardware of the user terminal 10 will be explained. FIG. 11 is a diagram showing an example of the hardware configuration of the user terminal 10.
 利用者端末10は、情報処理装置(所謂、コンピュータ)により構成可能であり、図11に例示する構成を備える。例えば、利用者端末10は、プロセッサ311、メモリ312、入出力インターフェイス313及び通信インターフェイス314等を備える。上記プロセッサ311等の構成要素は内部バス等により接続され、相互に通信可能に構成されている。 The user terminal 10 can be configured by an information processing device (so-called computer), and has the configuration illustrated in FIG. 11. For example, the user terminal 10 includes a processor 311, a memory 312, an input/output interface 313, a communication interface 314, and the like. The components such as the processor 311 are connected by an internal bus or the like and are configured to be able to communicate with each other.
 但し、図11に示す構成は、利用者端末10のハードウェア構成を限定する趣旨ではない。利用者端末10は、図示しないハードウェアを含んでもよいし、必要に応じて入出力インターフェイス313を備えていなくともよい。また、利用者端末10に含まれるプロセッサ311等の数も図11の例示に限定する趣旨ではなく、例えば、複数のプロセッサ311が利用者端末10に含まれていてもよい。 However, the configuration shown in FIG. 11 is not intended to limit the hardware configuration of the user terminal 10. The user terminal 10 may include hardware not shown, and may not include the input/output interface 313 if necessary. Furthermore, the number of processors 311 and the like included in the user terminal 10 is not limited to the example shown in FIG. 11; for example, a plurality of processors 311 may be included in the user terminal 10.
 プロセッサ311は、例えば、CPU(Central Processing Unit)、MPU(Micro Processing Unit)、DSP(Digital Signal Processor)等のプログラマブルなデバイスである。あるいは、プロセッサ311は、FPGA(Field Programmable Gate Array)、ASIC(Application Specific Integrated Circuit)等のデバイスであってもよい。プロセッサ311は、オペレーティングシステム(OS;Operating System)を含む各種プログラムを実行する。 The processor 311 is, for example, a programmable device such as a CPU (Central Processing Unit), an MPU (Micro Processing Unit), or a DSP (Digital Signal Processor). Alternatively, the processor 311 may be a device such as an FPGA (Field Programmable Gate Array) or an ASIC (Application Specific Integrated Circuit). The processor 311 executes various programs including an operating system (OS).
 メモリ312は、RAM(Random Access Memory)、ROM(Read Only Memory)、HDD(Hard Disk Drive)、SSD(Solid State Drive)等である。メモリ312は、OSプログラム、アプリケーションプログラム、各種データを格納する。 The memory 312 is a RAM (Random Access Memory), a ROM (Read Only Memory), an HDD (Hard Disk Drive), an SSD (Solid State Drive), or the like. The memory 312 stores OS programs, application programs, and various data.
 入出力インターフェイス313は、図示しない表示装置や入力装置のインターフェイスである。表示装置は、例えば、液晶ディスプレイ等である。入力装置は、例えば、キーボードやマウス等のユーザ操作を受け付ける装置である。 The input/output interface 313 is an interface for a display device or input device (not shown). The display device is, for example, a liquid crystal display. The input device is, for example, a device such as a keyboard or a mouse that receives user operations.
 通信インターフェイス314は、他の装置と通信を行う回路、モジュール等である。例えば、通信インターフェイス314は、NIC(Network Interface Card)等を備える。 The communication interface 314 is a circuit, module, etc. that communicates with other devices. For example, the communication interface 314 includes a NIC (Network Interface Card).
 利用者端末10の機能は、各種処理モジュールにより実現される。当該処理モジュールは、例えば、メモリ312に格納されたプログラムをプロセッサ311が実行することで実現される。また、当該プログラムは、コンピュータが読み取り可能な記憶媒体に記録することができる。記憶媒体は、半導体メモリ、ハードディスク、磁気記録媒体、光記録媒体等の非トランジェント(non-transitory)なものとすることができる。即ち、本発明は、コンピュータプログラム製品として具現することも可能である。また、上記プログラムは、ネットワークを介してダウンロードするか、あるいは、プログラムを記憶した記憶媒体を用いて、更新することができる。さらに、上記処理モジュールは、半導体チップにより実現されてもよい。 The functions of the user terminal 10 are realized by various processing modules. The processing module is realized, for example, by the processor 311 executing a program stored in the memory 312. Further, the program can be recorded on a computer-readable storage medium. The storage medium can be non-transitory, such as a semiconductor memory, a hard disk, a magnetic recording medium, an optical recording medium, etc. That is, the present invention can also be implemented as a computer program product. Furthermore, the above program can be updated via a network or by using a storage medium that stores the program. Furthermore, the processing module may be realized by a semiconductor chip.
 情報処理装置である利用者端末10は、コンピュータを搭載し、当該コンピュータにプログラムを実行させることで利用者端末10の機能が実現できる。また、利用者端末10は、当該プログラムにより利用者端末10の制御方法を実行する。 The user terminal 10, which is an information processing device, is equipped with a computer, and the functions of the user terminal 10 can be realized by having the computer execute a program. Further, the user terminal 10 executes the control method for the user terminal 10 using the program.
[変形例]
 なお、上記実施形態にて説明した情報処理システムの構成、動作等は例示であって、システムの構成等を限定する趣旨ではない。
[Modified example]
Note that the configuration, operation, etc. of the information processing system described in the above embodiments are merely examples, and are not intended to limit the configuration, etc. of the system.
 上記実施形態では、心不全を再発リスクのある病気の例にとり説明を行った。しかし、本願開示が適用可能な病気は心不全に限定されない。本願開示は、任意の病気に適用可能である。例えば、本願開示の利用者端末10(健康管理アプリケーション)は、心不全に限らず、その他循環器疾患や糖尿病等の他の疾患の再発や重症化に関する情報提供が可能である。 In the above embodiment, explanation was given using heart failure as an example of a disease with a risk of recurrence. However, diseases to which the present disclosure is applicable are not limited to heart failure. The present disclosure is applicable to any disease. For example, the user terminal 10 (health management application) disclosed in the present application is capable of providing information regarding not only heart failure but also recurrence or aggravation of other diseases such as circulatory diseases and diabetes.
 上記実施形態では、健康管理アプリケーションを起動する際に本人確認が実施されることを説明した。しかし、利用者端末10を起動する際に本人確認が行われる場合には、健康管理アプリケーション起動時の本人確認は省略されてもよい。 In the above embodiment, it has been explained that identity verification is performed when starting the health management application. However, if identity verification is performed when the user terminal 10 is activated, the identity verification upon activation of the health management application may be omitted.
 問診情報を入力中の利用者の生体情報(静止画データ又は動画データ)を取得する際、利用者端末10は、利用者を撮影することの同意を当該利用者から取得してもよい。あるいは、利用者端末10は、撮影中の画像データを問診情報の入力画面に表示してもよい。 When acquiring biometric information (still image data or video data) of a user who is inputting medical interview information, the user terminal 10 may acquire consent from the user to photograph the user. Alternatively, the user terminal 10 may display the image data being captured on the interview information input screen.
 上記実施形態では、利用者端末10は、図5に示すようなGUIを用いて問診情報を取得する場合について説明した。しかし、問診情報は他の方法によって取得されてもよい。例えば、利用者端末10は、音声入力により問診情報を取得してもよい。あるいは、利用者端末10は、設問選択やチャットボット等での回答により問診情報を取得してもよい。 In the above embodiment, a case has been described in which the user terminal 10 acquires medical interview information using a GUI as shown in FIG. However, the interview information may be obtained by other methods. For example, the user terminal 10 may acquire medical interview information through voice input. Alternatively, the user terminal 10 may acquire medical interview information by selecting questions or responding through a chatbot or the like.
 上記実施形態では、利用者端末10は、GUIを用いて利用者本人から問診情報を取得する場合について説明した。しかし、利用者端末10は、利用者が利用者端末10を操作する態様(操作の仕方)等に応じて問診情報の全部又は一部を推定してもよい。例えば、利用者端末10は、利用者による文字入力の正確さや円滑さ等に基づいて「認知症」の有無を推定してもよい。例えば、利用者端末10は、過去のデータ入力に要した時間や入力ミスの頻度等に基づいて、利用者がデータ入力に多くの時間を費やしている場合や入力ミスが極端に増えたと判定した場合に、当該利用者は「認知症」に罹患していると推定してもよい。 In the above embodiment, a case has been described in which the user terminal 10 acquires medical interview information from the user himself/herself using the GUI. However, the user terminal 10 may estimate all or part of the interview information depending on the manner in which the user operates the user terminal 10 (how the user operates). For example, the user terminal 10 may estimate the presence or absence of "dementia" based on the accuracy and smoothness of character input by the user. For example, the user terminal 10 determines that the user is spending a lot of time inputting data or that the number of input errors has increased significantly based on the time required for past data input and the frequency of input errors. In some cases, the user may be presumed to be suffering from "dementia."
 上記実施形態では、利用者端末10が、バイタルデータの推定に必要な生体情報(顔画像を含む画像データ)を利用者が問診情報を入力している最中に取得することを説明した。しかし、当該生体情報は、問診情報の入力時に限らず、利用者が他のアプリケーション等を操作している際に取得されてもよい。例えば、利用者端末10は、利用者がSNS(Social Networking Service)アプリケーションの利用中やWEB(ウェブ)ページを閲覧中に生体情報を取得してもよい。 In the above embodiment, it has been explained that the user terminal 10 acquires biological information (image data including a face image) necessary for estimating vital data while the user is inputting medical interview information. However, the biometric information may be acquired not only when inputting medical interview information but also when the user is operating another application or the like. For example, the user terminal 10 may acquire biometric information while the user is using an SNS (Social Networking Service) application or browsing a WEB page.
 利用者端末10は、問診情報(例えば、服薬情報、睡眠情報等)の全部又は一部を健康管理アプリケーションとは異なるアプリケーション等から取得してもよい。例えば、利用者端末10は、服薬を管理するアプリケーションや睡眠の良し悪しを測定するアプリケーション等から問診情報を取得してもよい。 The user terminal 10 may acquire all or part of the medical interview information (for example, medication information, sleep information, etc.) from an application different from the health management application. For example, the user terminal 10 may acquire medical interview information from an application that manages medication, an application that measures the quality of sleep, or the like.
 利用者端末10は、問診情報が定期的に入力されていないことを検出した場合には、その旨を支援者(例えば、かかりつけ医や家族)に通知してもよい。あるいは、利用者端末10は、取得した問診情報に基づいて、利用者が必要な服薬をしていないと判定した場合(服薬忘れの場合)にはその旨を本人や支援者(例えば、家族)に通知してもよい。あるいは、利用者端末10は、利用者の食事内容を取得できた場合であって、利用者が塩分を取り過ぎている場合や水分量が足りない場合に、その旨を本人や支援者に通知してもよい。 If the user terminal 10 detects that medical interview information is not regularly input, it may notify a support person (for example, a family doctor or a family member) of this fact. Alternatively, if the user terminal 10 determines that the user has not taken the necessary medication (forgot to take the medication) based on the acquired interview information, the user terminal 10 may notify the user or a supporter (for example, a family member) to that effect. may be notified. Alternatively, if the user terminal 10 is able to obtain the user's meal contents and the user is consuming too much salt or not enough water, the user terminal 10 notifies the user or a supporter to that effect. You may.
 利用者は、血圧や心拍数等の測定が可能な端末(所謂、ウェアラブルデバイス)を装着してもよい。利用者端末10は、当該ウェアラブルデバイスからバイタルデータを取得してもよい。具体的には、利用者端末10は、Bluetooth(登録商標)等の近距離無線通信手段によりウェアラブルデバイスが測定したバイタルデータを取得してもよい。利用者端末10は、病気再発リスク値の算出に必要なバイタルデータの全部又は一部をウェアラブルデバイスから取得したバイタルデータを用いてもよい。即ち、利用者端末10は、他のデバイス(健康器具;例えば、ウェアラブルデバイス、体重計、血圧計)から取得したバイタルデータを用いて病気再発リスク値を算出してもよい。 The user may wear a terminal (so-called wearable device) that can measure blood pressure, heart rate, etc. The user terminal 10 may acquire vital data from the wearable device. Specifically, the user terminal 10 may acquire vital data measured by the wearable device using short-range wireless communication means such as Bluetooth (registered trademark). The user terminal 10 may use vital data acquired from a wearable device as all or part of the vital data necessary for calculating the disease recurrence risk value. That is, the user terminal 10 may calculate the disease recurrence risk value using vital data acquired from other devices (health equipment; for example, a wearable device, a scale, a blood pressure monitor).
 利用者端末10は、利用者の顔だけでなく、利用者の全体が写る画像データを生体情報として取得してもよい。あるいは、利用者端末10は、利用者の顔の一部が写る画像データを生体情報として取得してもよい。例えば、利用者端末10は、利用者の両目(瞳孔)が写る画像データ(静止画データ、動画データ)を生体情報として取得してもよい。 The user terminal 10 may acquire image data showing not only the user's face but also the entire user as biometric information. Alternatively, the user terminal 10 may acquire image data showing part of the user's face as biometric information. For example, the user terminal 10 may acquire image data (still image data, video data) showing both eyes (pupils) of the user as biometric information.
 利用者端末10は、取得した全身の画像データや瞳孔の画像データを用いてバイタルデータを推定してもよい。例えば、利用者端末10は、肩の動きから心拍数、呼吸数等を推定してもよいし、瞳孔の大きさ(広がり)をバイタルデータとして取得してもよい。 The user terminal 10 may estimate vital data using the acquired whole body image data and pupil image data. For example, the user terminal 10 may estimate heart rate, breathing rate, etc. from shoulder movements, or may acquire the size (dilation) of pupils as vital data.
 利用者端末10(問診情報制御部203)は、推定するバイタルデータの種類に応じて、使用する生体情報(静止画データ、動画データ)や学習モデルを使い分けしてもよい。例えば、体重を推定する場合には、利用者端末10は、静止画データ(動画データの一部)を、体重推定専用の学習モデルに入力することで、利用者の体重を推定する。あるいは、血圧や心拍数を推定する場合には、利用者端末10は、動画データ(複数の静止画データ)を、血圧推定専用や心拍数推定専用の学習モデルに入力することで、利用者の血圧、心拍数を推定する。利用者端末10は、推定するバイタルデータに適した生体情報、学習モデルを使用することで、より精度の高いバイタルデータを得ることができる。あるいは、利用者端末10は、推定するバイタルデータに適した動画データ等を取得してもよい。例えば、利用者端末10は、推定するバイタルデータに適したフレームレートの動画を取得(生成)してもよい。 The user terminal 10 (interview information control unit 203) may use different biological information (still image data, video data) and learning models depending on the type of vital data to be estimated. For example, when estimating the weight, the user terminal 10 estimates the user's weight by inputting still image data (part of the video data) to a learning model dedicated to weight estimation. Alternatively, when estimating blood pressure or heart rate, the user terminal 10 inputs video data (a plurality of still image data) into a learning model dedicated to blood pressure estimation or heart rate estimation, so that the user's Estimate blood pressure and heart rate. The user terminal 10 can obtain more accurate vital data by using biological information and a learning model suitable for the vital data to be estimated. Alternatively, the user terminal 10 may acquire video data or the like suitable for the vital data to be estimated. For example, the user terminal 10 may acquire (generate) a video with a frame rate suitable for the estimated vital data.
 利用者端末10は、取得した生体情報をバイタルデータの推定以外の用途に使用してもよい。例えば、利用者端末10は、認知症への罹患有無や遺伝子疾患の有無等を、取得した生体情報を用いて推定してもよい。例えば、利用者端末10は、利用者の顔画像を含む静止画データを学習モデルに入力することで、認知症への罹患有無や遺伝子疾患の有無等を判定してもよい。 The user terminal 10 may use the acquired biometric information for purposes other than estimating vital data. For example, the user terminal 10 may estimate the presence or absence of dementia, the presence or absence of a genetic disease, etc. using the acquired biological information. For example, the user terminal 10 may determine the presence or absence of dementia, the presence or absence of a genetic disease, etc. by inputting still image data including a user's face image into a learning model.
 あるいは、利用者端末10は、取得した生体情報を用いて問診情報を推定(生成)してもよい。例えば、利用者端末10は、顔画像を学習モデルに入力することで、「疲れやすさ」を推定してもよい。あるいは、利用者端末10は、取得した生体情報を学習モデルに入力することで、利用者の感情(喜怒哀楽)を推定してもよい。即ち、利用者端末10は、利用者の「表情」を解析することで利用者の感情(気持ち、気分)を推定してもよい。あるいは、利用者端末10は、利用者の年代に応じて、使用する学習モデル等を使い分けてもよい。 Alternatively, the user terminal 10 may estimate (generate) the interview information using the acquired biometric information. For example, the user terminal 10 may estimate "easiness to get tired" by inputting a face image into a learning model. Alternatively, the user terminal 10 may estimate the user's emotions (emotions, anger, sadness, and happiness) by inputting the acquired biological information into a learning model. That is, the user terminal 10 may estimate the user's emotions (feelings, mood) by analyzing the user's “facial expressions”. Alternatively, the user terminal 10 may use different learning models or the like depending on the age of the user.
 利用者端末10は、最新のバイタルデータ推定値だけでなく、過去に取得されたバイタルデータ推定値を用いて病気再発リスク値を算出してもよい。例えば、利用者端末10は、所定期間(例えば、1週間)に亘り取得されたバイタルデータ推定値を学習モデルに入力することで病気再発リスク値を算出してもよい。この場合、バイタルデータ推定値の変化(変化の割合)等が考慮され病気再発リスク値が算出されるので、より正確に病気再発リスクが把握される。同様に、利用者端末10は、所定期間のバイタルデータ推定値と問診情報を用いて病気再発リスク値を算出してもよい。 The user terminal 10 may calculate the disease recurrence risk value using not only the latest vital data estimate but also the vital data estimate acquired in the past. For example, the user terminal 10 may calculate the disease recurrence risk value by inputting estimated values of vital data acquired over a predetermined period (for example, one week) into a learning model. In this case, the disease recurrence risk value is calculated by taking into account the change (rate of change) in the estimated value of vital data, so that the disease recurrence risk can be grasped more accurately. Similarly, the user terminal 10 may calculate a disease recurrence risk value using estimated values of vital data and interview information for a predetermined period.
 上記実施形態では、利用者端末10は、病気再発リスク値が所定値よりも低い場合には特段の動作(通知)を行わないことを説明した。しかし、病気再発リスク値が低い場合には、利用者端末10は、病気再発リスクが低い事実を利用者本人又は支援者に通知してもよい。 In the above embodiment, it has been explained that the user terminal 10 does not perform any special operation (notification) when the disease recurrence risk value is lower than a predetermined value. However, if the disease recurrence risk value is low, the user terminal 10 may notify the user or the supporter of the fact that the disease recurrence risk is low.
 利用者端末10は、病気再発リスクの程度により、健康情報の通知先や通知内容を変更してもよい。例えば、病気再発リスクが非常に高い場合(病気再発リスク値が所定の閾値よりも大きい場合)には、利用者端末10は、本人及び支援者にその旨を通知する。対して、再発リスクがさほど高くない場合には、利用者端末10は、本人に生活改善等のアドバイスをすることに留めてもよい。利用者端末10は、病気再発リスク値が第1の閾値を超えた場合には利用者本人に健康情報を送信し、病気再発リスク値が第2の閾値を超えた場合には利用者と支援者に健康情報を送信してもよい。 The user terminal 10 may change the health information notification destination and notification content depending on the degree of disease recurrence risk. For example, if the risk of disease recurrence is extremely high (if the disease recurrence risk value is greater than a predetermined threshold), the user terminal 10 notifies the person and the support person to that effect. On the other hand, if the risk of recurrence is not so high, the user terminal 10 may limit itself to giving the person advice on how to improve his or her lifestyle. The user terminal 10 sends health information to the user when the disease recurrence risk value exceeds a first threshold, and sends support to the user when the disease recurrence risk value exceeds a second threshold. You may send health information to others.
 利用者端末10が生成した健康手帳(問診情報、バイタルデータ推定値の集合)は、医療機関等と共有されてもよい。例えば、利用者が利用者端末10を操作することで、オンライン診療時に健康手帳(健康管理データベースの内容)が医療機関に提出されてもよい。 The health notebook (collection of medical interview information and estimated vital data) generated by the user terminal 10 may be shared with medical institutions and the like. For example, a user may operate the user terminal 10 to submit a health notebook (contents of a health management database) to a medical institution during online medical treatment.
 上記実施形態では、利用者端末10が生成した健康情報(病気再発リスク値、問診情報、バイタルデータ推定値)が支援者等に提供されることを説明した。しかし、当該健康情報は、民間企業や自治体等の公共機関に提供されてもよい。例えば、利用者端末10は、利用者の同意の下、問診情報やバイタルデータの推定値を保険会社や小売業者に提供してもよい。当該問診情報やバイタルデータ推定値を提供した利用者には、金銭が支払われてもよい。即ち、問診情報、バイタルデータ推定値に関するデータ利活用ビジネスが行われてもよい。例えば、保険商品の開発のために保険会社にデータが提供されてもよいし、健康食品の販促のために小売業者にデータが提供されてもよい。 In the above embodiment, it has been explained that the health information (disease recurrence risk value, medical interview information, estimated vital data) generated by the user terminal 10 is provided to supporters and the like. However, the health information may also be provided to public institutions such as private companies and local governments. For example, the user terminal 10 may provide interview information and estimated values of vital data to an insurance company or retailer with the consent of the user. Money may be paid to the user who provided the interview information and estimated vital data. That is, a data utilization business regarding medical interview information and estimated values of vital data may be conducted. For example, data may be provided to insurance companies for the development of insurance products, or data may be provided to retailers to promote health foods.
 利用者端末10は、問診情報の入力対する動機付けのため、利用者が問診情報を入力するたびに当該利用者にポイントを付与してもよい。 The user terminal 10 may award points to the user each time the user inputs the interview information, in order to motivate the user to input the interview information.
 上記実施形態では、利用者端末10の内部に健康管理データベースが構成される場合について説明したが、当該データベースは外部のデータベースサーバ等に構築されてもよい。即ち、情報処理システムにサーバ装置が含まれ、当該サーバ装置が、各利用者の健康状態(問診情報、バイタルデータ推定値)を管理してもよい。また、当該サーバ装置が、健康情報の通知に関する制御(健康情報の提供)を行ってもよい。即ち、利用者端末10の一部の機能は別の装置、デバイス等に実装されていてもよい。 In the above embodiment, a case has been described in which the health management database is configured inside the user terminal 10, but the database may be configured in an external database server or the like. That is, the information processing system may include a server device, and the server device may manage the health status (interview information, estimated vital data) of each user. Further, the server device may perform control regarding notification of health information (provision of health information). That is, some functions of the user terminal 10 may be implemented in another apparatus, device, or the like.
 各装置(利用者端末10、支援者端末20)間のデータ送受信の形態は特に限定されないが、これら装置間で送受信されるデータは暗号化されていてもよい。これらの装置間では、問診情報等の個人情報が送受信され、これらの情報を適切に保護するためには、暗号化されたデータが送受信されることが望ましい。 The form of data transmission and reception between each device (user terminal 10, supporter terminal 20) is not particularly limited, but data transmitted and received between these devices may be encrypted. Personal information such as medical interview information is transmitted and received between these devices, and in order to appropriately protect this information, it is desirable that encrypted data be transmitted and received.
 上記説明で用いた流れ図(フローチャート、シーケンス図)では、複数の工程(処理)が順番に記載されているが、実施形態で実行される工程の実行順序は、その記載の順番に制限されない。実施形態では、例えば各処理を並行して実行する等、図示される工程の順番を内容的に支障のない範囲で変更することができる。 Although a plurality of steps (processes) are described in order in the flowcharts (flowcharts, sequence diagrams) used in the above description, the order in which the steps are executed in the embodiment is not limited to the order in which they are described. In the embodiment, the order of the illustrated steps can be changed within a range that does not affect the content, such as executing each process in parallel, for example.
 上記の実施形態は本願開示の理解を容易にするために詳細に説明したものであり、上記説明したすべての構成が必要であることを意図したものではない。また、複数の実施形態について説明した場合には、各実施形態は単独で用いてもよいし、組み合わせて用いてもよい。例えば、実施形態の構成の一部を他の実施形態の構成に置き換えることや、実施形態の構成に他の実施形態の構成を加えることも可能である。さらに、実施形態の構成の一部について他の構成の追加、削除、置換が可能である。 The above embodiments have been described in detail to facilitate understanding of the present disclosure, and it is not intended that all the configurations described above are necessary. Further, when a plurality of embodiments are described, each embodiment may be used alone or in combination. For example, it is also possible to replace a part of the configuration of the embodiment with the configuration of another embodiment, or to add the configuration of another embodiment to the configuration of the embodiment. Furthermore, it is possible to add, delete, or replace some of the configurations of the embodiments with other configurations.
 上記の説明により、本発明の産業上の利用可能性は明らかであるが、本発明は、利用者に健康に関する情報提供を行う情報処理システムなどに好適に適用可能である。 The industrial applicability of the present invention is clear from the above description, and the present invention is suitably applicable to information processing systems that provide health-related information to users.
 上記の実施形態の一部又は全部は、以下の付記のようにも記載され得るが、以下には限られない。
[付記1]
 利用者の生体情報を取得する、取得手段と、
 前記取得された生体情報に基づいてバイタルデータを推定する、推定手段と、
 前記推定されたバイタルデータに基づいて前記利用者の病気再発リスクを示す病気再発リスク値を算出する、算出手段と、
 前記算出された病気再発リスク値に応じた情報提供を行う、提供手段と、
 を備える、端末。
[付記2]
 前記取得手段は、前記利用者の問診情報を取得し、
 前記算出手段は、前記問診情報と前記推定されたバイタルデータに基づいて、前記病気再発リスク値を算出する、付記1に記載の端末。
[付記3]
 前記取得手段は、前記利用者が前記問診情報を入力している間に前記生体情報を取得する、付記2に記載の端末。
[付記4]
 前記提供手段は、前記病気再発リスク値に基づいて、前記利用者及び前記利用者の支援者のうち少なくとも一方に前記利用者の健康に関する情報を提供する、付記3に記載の端末。
[付記5]
 前記提供手段は、前記病気再発リスク値が所定値以上の場合、前記利用者に対して病気再発のリスクが高いことを通知する、付記4に記載の端末。
[付記6]
 前記提供手段は、前記病気再発リスク値が所定値以上の場合、前記利用者を支援する支援者に対して病気再発のリスクが高いことを通知する、付記4に記載の端末。
[付記7]
 前記利用者が前記問診情報を入力する前に、前記利用者の本人確認を行う、本人確認手段をさらに備える、付記4に記載の端末。
[付記8]
 前記取得手段は、前記利用者を撮影することで得られる静止画データ又は動画データを前記生体情報として取得する、付記1乃至7のいずれか一項に記載の端末。
[付記9]
 端末において、
 利用者の生体情報を取得し、
 前記取得された生体情報に基づいてバイタルデータを推定し、
 前記推定されたバイタルデータに基づいて前記利用者の病気再発リスクを示す病気再発リスク値を算出し、
 前記算出された病気再発リスク値に応じた情報提供を行う、端末の制御方法。
[付記10]
 端末に搭載されたコンピュータに、
 利用者の生体情報を取得する処理と、
 前記取得された生体情報に基づいてバイタルデータを推定する処理と、
 前記推定されたバイタルデータに基づいて前記利用者の病気再発リスクを示す病気再発リスク値を算出する処理と、
 前記算出された病気再発リスク値に応じた情報提供を行う処理と、
 を実行させるためのプログラムを記憶する、コンピュータ読取可能な記憶媒体。
Part or all of the above embodiments may be described as in the following additional notes, but are not limited to the following.
[Additional note 1]
an acquisition means for acquiring biometric information of a user;
Estimating means for estimating vital data based on the acquired biological information;
Calculation means for calculating a disease recurrence risk value indicating the risk of disease recurrence of the user based on the estimated vital data;
Providing means for providing information according to the calculated disease recurrence risk value;
A terminal equipped with
[Additional note 2]
The acquisition means acquires interview information of the user,
The terminal according to supplementary note 1, wherein the calculation means calculates the disease recurrence risk value based on the interview information and the estimated vital data.
[Additional note 3]
The terminal according to supplementary note 2, wherein the acquisition means acquires the biometric information while the user is inputting the medical interview information.
[Additional note 4]
The terminal according to appendix 3, wherein the providing means provides information regarding the user's health to at least one of the user and the user's supporter based on the disease recurrence risk value.
[Additional note 5]
The terminal according to supplementary note 4, wherein the providing means notifies the user that the risk of disease recurrence is high when the disease recurrence risk value is equal to or higher than a predetermined value.
[Additional note 6]
The terminal according to supplementary note 4, wherein the providing means notifies a supporter who supports the user that the risk of disease recurrence is high when the disease recurrence risk value is equal to or higher than a predetermined value.
[Additional note 7]
The terminal according to supplementary note 4, further comprising an identity verification means for verifying the identity of the user before the user inputs the medical interview information.
[Additional note 8]
8. The terminal according to any one of Supplementary Notes 1 to 7, wherein the acquisition means acquires still image data or video data obtained by photographing the user as the biometric information.
[Additional note 9]
At the terminal,
Obtain the user's biometric information,
Estimating vital data based on the acquired biological information,
Calculating a disease recurrence risk value indicating the user's disease recurrence risk based on the estimated vital data,
A terminal control method for providing information according to the calculated disease recurrence risk value.
[Additional note 10]
On the computer installed in the terminal,
Processing to obtain biometric information of the user;
a process of estimating vital data based on the acquired biological information;
a process of calculating a disease recurrence risk value indicating the disease recurrence risk of the user based on the estimated vital data;
a process of providing information according to the calculated disease recurrence risk value;
A computer-readable storage medium that stores a program for executing.
 なお、引用した上記の先行技術文献の各開示は、本書に引用をもって繰り込むものとする。以上、本発明の実施形態を説明したが、本発明はこれらの実施形態に限定されるものではない。これらの実施形態は例示にすぎないということ、及び、本発明のスコープ及び精神から逸脱することなく様々な変形が可能であるということは、当業者に理解されるであろう。即ち、本発明は、請求の範囲を含む全開示、技術的思想にしたがって当業者であればなし得る各種変形、修正を含むことは勿論である。 Furthermore, each disclosure of the cited prior art documents mentioned above shall be incorporated into this document by reference. Although the embodiments of the present invention have been described above, the present invention is not limited to these embodiments. It will be understood by those skilled in the art that these embodiments are illustrative only and that various modifications can be made without departing from the scope and spirit of the invention. That is, it goes without saying that the present invention includes the entire disclosure including the claims and various modifications and modifications that can be made by those skilled in the art in accordance with the technical idea.
10 利用者端末
20 支援者端末
100 端末
101 取得手段
102 推定手段
103 算出手段
104 提供手段
201 通信制御部
202 本人確認部
203 問診情報制御部
204 再発リスク管理部
205 健康情報提供部
206 記憶部
311 プロセッサ
312 メモリ
313 入出力インターフェイス
314 通信インターフェイス
10 User terminal 20 Supporter terminal 100 Terminal 101 Acquisition means 102 Estimation means 103 Calculation means 104 Providing means 201 Communication control section 202 Identity confirmation section 203 Medical interview information control section 204 Recurrence risk management section 205 Health information provision section 206 Storage section 311 Processor 312 Memory 313 Input/output interface 314 Communication interface

Claims (10)

  1.  利用者の生体情報を取得する、取得手段と、
     前記取得された生体情報に基づいてバイタルデータを推定する、推定手段と、
     前記推定されたバイタルデータに基づいて前記利用者の病気再発リスクを示す病気再発リスク値を算出する、算出手段と、
     前記算出された病気再発リスク値に応じた情報提供を行う、提供手段と、
     を備える、端末。
    an acquisition means for acquiring biometric information of a user;
    Estimating means for estimating vital data based on the acquired biological information;
    Calculation means for calculating a disease recurrence risk value indicating the risk of disease recurrence of the user based on the estimated vital data;
    Providing means for providing information according to the calculated disease recurrence risk value;
    A terminal equipped with
  2.  前記取得手段は、前記利用者の問診情報を取得し、
     前記算出手段は、前記問診情報と前記推定されたバイタルデータに基づいて、前記病気再発リスク値を算出する、請求項1に記載の端末。
    The acquisition means acquires interview information of the user,
    The terminal according to claim 1, wherein the calculation means calculates the disease recurrence risk value based on the interview information and the estimated vital data.
  3.  前記取得手段は、前記利用者が前記問診情報を入力している間に前記生体情報を取得する、請求項2に記載の端末。 The terminal according to claim 2, wherein the acquisition means acquires the biometric information while the user is inputting the medical interview information.
  4.  前記提供手段は、前記病気再発リスク値に基づいて、前記利用者及び前記利用者の支援者のうち少なくとも一方に前記利用者の健康に関する情報を提供する、請求項3に記載の端末。 The terminal according to claim 3, wherein the providing means provides information regarding the user's health to at least one of the user and the user's supporter based on the disease recurrence risk value.
  5.  前記提供手段は、前記病気再発リスク値が所定値以上の場合、前記利用者に対して病気再発のリスクが高いことを通知する、請求項4に記載の端末。 The terminal according to claim 4, wherein the providing means notifies the user that the risk of disease recurrence is high when the disease recurrence risk value is equal to or higher than a predetermined value.
  6.  前記提供手段は、前記病気再発リスク値が所定値以上の場合、前記利用者を支援する支援者に対して病気再発のリスクが高いことを通知する、請求項4に記載の端末。 5. The terminal according to claim 4, wherein the providing means notifies a supporter who supports the user that the risk of disease recurrence is high when the disease recurrence risk value is equal to or higher than a predetermined value.
  7.  前記利用者が前記問診情報を入力する前に、前記利用者の本人確認を行う、本人確認手段をさらに備える、請求項4に記載の端末。 The terminal according to claim 4, further comprising an identity verification means for verifying the identity of the user before the user inputs the medical interview information.
  8.  前記取得手段は、前記利用者を撮影することで得られる静止画データ又は動画データを前記生体情報として取得する、請求項1乃至7のいずれか一項に記載の端末。 The terminal according to any one of claims 1 to 7, wherein the acquisition means acquires still image data or video data obtained by photographing the user as the biometric information.
  9.  端末において、
     利用者の生体情報を取得し、
     前記取得された生体情報に基づいてバイタルデータを推定し、
     前記推定されたバイタルデータに基づいて前記利用者の病気再発リスクを示す病気再発リスク値を算出し、
     前記算出された病気再発リスク値に応じた情報提供を行う、端末の制御方法。
    At the terminal,
    Obtain the user's biometric information,
    Estimating vital data based on the acquired biological information,
    Calculating a disease recurrence risk value indicating the user's disease recurrence risk based on the estimated vital data,
    A terminal control method for providing information according to the calculated disease recurrence risk value.
  10.  端末に搭載されたコンピュータに、
     利用者の生体情報を取得する処理と、
     前記取得された生体情報に基づいてバイタルデータを推定する処理と、
     前記推定されたバイタルデータに基づいて前記利用者の病気再発リスクを示す病気再発リスク値を算出する処理と、
     前記算出された病気再発リスク値に応じた情報提供を行う処理と、
     を実行させるためのプログラムを記憶する、コンピュータ読取可能な記憶媒体。
    On the computer installed in the terminal,
    Processing to obtain biometric information of the user;
    a process of estimating vital data based on the acquired biological information;
    a process of calculating a disease recurrence risk value indicating the risk of disease recurrence of the user based on the estimated vital data;
    a process of providing information according to the calculated disease recurrence risk value;
    A computer-readable storage medium that stores a program for executing.
PCT/JP2022/031726 2022-08-23 2022-08-23 Terminal, method for controlling terminal, and storage medium WO2024042613A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/JP2022/031726 WO2024042613A1 (en) 2022-08-23 2022-08-23 Terminal, method for controlling terminal, and storage medium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2022/031726 WO2024042613A1 (en) 2022-08-23 2022-08-23 Terminal, method for controlling terminal, and storage medium

Publications (1)

Publication Number Publication Date
WO2024042613A1 true WO2024042613A1 (en) 2024-02-29

Family

ID=90012726

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/031726 WO2024042613A1 (en) 2022-08-23 2022-08-23 Terminal, method for controlling terminal, and storage medium

Country Status (1)

Country Link
WO (1) WO2024042613A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015050174A1 (en) * 2013-10-01 2015-04-09 国立大学法人東北大学 Health information procssing device, health information display device, and method
JP2016059759A (en) * 2014-09-22 2016-04-25 株式会社メディプリーム Pathogenesis prediction network system
JP2016140641A (en) * 2015-02-04 2016-08-08 セイコーエプソン株式会社 Biological information measuring apparatus
JP2016190022A (en) * 2015-03-30 2016-11-10 国立大学法人東北大学 Biological information measuring device, biological information measuring method, biological information display device and biological information display method
JP2019115614A (en) * 2017-12-27 2019-07-18 オムロンヘルスケア株式会社 Disease onset risk estimation device, method and program
JP2022011919A (en) * 2020-06-30 2022-01-17 フクダ電子株式会社 Biological information providing device, biological information providing method, and biological information providing program

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015050174A1 (en) * 2013-10-01 2015-04-09 国立大学法人東北大学 Health information procssing device, health information display device, and method
JP2016059759A (en) * 2014-09-22 2016-04-25 株式会社メディプリーム Pathogenesis prediction network system
JP2016140641A (en) * 2015-02-04 2016-08-08 セイコーエプソン株式会社 Biological information measuring apparatus
JP2016190022A (en) * 2015-03-30 2016-11-10 国立大学法人東北大学 Biological information measuring device, biological information measuring method, biological information display device and biological information display method
JP2019115614A (en) * 2017-12-27 2019-07-18 オムロンヘルスケア株式会社 Disease onset risk estimation device, method and program
JP2022011919A (en) * 2020-06-30 2022-01-17 フクダ電子株式会社 Biological information providing device, biological information providing method, and biological information providing program

Similar Documents

Publication Publication Date Title
US20180358117A1 (en) System and Method for Personal Health Information Exchange
US20180350455A1 (en) Sensor-enabled mobile health monitoring and diagnosis
De San Miguel et al. Telehealth remote monitoring for community-dwelling older adults with chronic obstructive pulmonary disease
US9955869B2 (en) System and method for supporting health management services
KR102144532B1 (en) Method for operating connected personal health record service based on block chain
Triantafyllidis et al. A survey of mobile phone sensing, self-reporting, and social sharing for pervasive healthcare
KR20190079157A (en) Online based health care method and apparatus
JP2019036350A (en) Systems and methods for administering health care systems
CN108778097A (en) Device and method for assessing heart failure
Azimi et al. Personalized maternal sleep quality assessment: An objective iot-based longitudinal study
US20220246299A1 (en) Electronic patient advisor and healthcare system for remote management of chronic conditions
Khowaja et al. VIRFIM: an AI and Internet of Medical Things-driven framework for healthcare using smart sensors
AU2021257997A1 (en) Methods and Systems for Predicting a Diagnosis of Musculoskeletal Pathologies
Khowaja et al. Internet of Everything enabled solution for COVID-19, its new variants and future pandemics: Framework, Challenges, and Research Directions
Chauvin et al. Building the thermometer for mental health
US20240138780A1 (en) Digital kiosk for performing integrative analysis of health and disease condition and method thereof
US20220192556A1 (en) Predictive, diagnostic and therapeutic applications of wearables for mental health
Awasthi et al. AI and IoT-based intelligent health care & sanitation
Al Thawadi et al. Disruptive IoT-based healthcare insurance business model
WO2024042613A1 (en) Terminal, method for controlling terminal, and storage medium
AU2016200158A1 (en) System and method for autonomous chronic disease management
Navarro-Alamán et al. Close2U: an app for monitoring cancer patients with enriched information from interaction patterns
Ayouni et al. Development of a Smart Hospital Bed Based on Deep Learning to Monitor Patient Conditions
Volkov et al. Architecture of mHealth Platform for Storing, Exchanging and Processing of Medical Data in Smart Healthcare
Roy et al. An overview of artificial intelligence (AI) intervention in Indian healthcare system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22956441

Country of ref document: EP

Kind code of ref document: A1